JP5954321B2 - Method for producing radial zinc oxide particles - Google Patents
Method for producing radial zinc oxide particles Download PDFInfo
- Publication number
- JP5954321B2 JP5954321B2 JP2013519540A JP2013519540A JP5954321B2 JP 5954321 B2 JP5954321 B2 JP 5954321B2 JP 2013519540 A JP2013519540 A JP 2013519540A JP 2013519540 A JP2013519540 A JP 2013519540A JP 5954321 B2 JP5954321 B2 JP 5954321B2
- Authority
- JP
- Japan
- Prior art keywords
- zinc oxide
- zinc
- oxide particles
- particles
- radial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 title claims description 208
- 239000002245 particle Substances 0.000 title claims description 157
- 239000011787 zinc oxide Substances 0.000 title claims description 104
- 238000004519 manufacturing process Methods 0.000 title claims description 18
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 57
- 229940007718 zinc hydroxide Drugs 0.000 claims description 43
- 229910021511 zinc hydroxide Inorganic materials 0.000 claims description 43
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 39
- 239000011701 zinc Substances 0.000 claims description 32
- 239000007864 aqueous solution Substances 0.000 claims description 31
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 28
- 229910052725 zinc Inorganic materials 0.000 claims description 28
- UGZADUVQMDAIAO-UHFFFAOYSA-L zinc hydroxide Chemical compound [OH-].[OH-].[Zn+2] UGZADUVQMDAIAO-UHFFFAOYSA-L 0.000 claims description 25
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 claims description 21
- 239000004246 zinc acetate Substances 0.000 claims description 21
- 238000002156 mixing Methods 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 47
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 44
- 239000000284 extract Substances 0.000 description 40
- -1 amine compound Chemical class 0.000 description 36
- 238000000034 method Methods 0.000 description 26
- 235000011114 ammonium hydroxide Nutrition 0.000 description 25
- 239000000243 solution Substances 0.000 description 23
- 229910021529 ammonia Inorganic materials 0.000 description 20
- 239000003921 oil Substances 0.000 description 20
- 235000019198 oils Nutrition 0.000 description 20
- 239000000126 substance Substances 0.000 description 19
- 239000002537 cosmetic Substances 0.000 description 18
- 238000003756 stirring Methods 0.000 description 17
- 235000014113 dietary fatty acids Nutrition 0.000 description 16
- 239000000194 fatty acid Substances 0.000 description 16
- 229930195729 fatty acid Natural products 0.000 description 16
- 239000000203 mixture Substances 0.000 description 15
- 239000011342 resin composition Substances 0.000 description 15
- 229920005989 resin Polymers 0.000 description 14
- 239000011347 resin Substances 0.000 description 14
- 238000002441 X-ray diffraction Methods 0.000 description 13
- 239000000945 filler Substances 0.000 description 13
- 239000004166 Lanolin Substances 0.000 description 12
- 235000019388 lanolin Nutrition 0.000 description 12
- 229940039717 lanolin Drugs 0.000 description 12
- 238000001228 spectrum Methods 0.000 description 12
- YZYKBQUWMPUVEN-UHFFFAOYSA-N zafuleptine Chemical compound OC(=O)CCCCCC(C(C)C)NCC1=CC=C(F)C=C1 YZYKBQUWMPUVEN-UHFFFAOYSA-N 0.000 description 12
- 239000004359 castor oil Substances 0.000 description 11
- 235000019438 castor oil Nutrition 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 238000000635 electron micrograph Methods 0.000 description 11
- 238000001914 filtration Methods 0.000 description 11
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 11
- 238000005406 washing Methods 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 229920000642 polymer Polymers 0.000 description 10
- 238000001035 drying Methods 0.000 description 9
- 230000017525 heat dissipation Effects 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 238000010992 reflux Methods 0.000 description 9
- 238000001878 scanning electron micrograph Methods 0.000 description 9
- 238000005979 thermal decomposition reaction Methods 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 150000004665 fatty acids Chemical class 0.000 description 7
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 6
- 230000000704 physical effect Effects 0.000 description 6
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000004519 grease Substances 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- 239000003973 paint Substances 0.000 description 5
- 239000002243 precursor Substances 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- DSSYKIVIOFKYAU-OIBJUYFYSA-N (S)-camphor Chemical compound C1C[C@]2(C)C(=O)C[C@H]1C2(C)C DSSYKIVIOFKYAU-OIBJUYFYSA-N 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- 229920001214 Polysorbate 60 Polymers 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- 229920003169 water-soluble polymer Polymers 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000019864 coconut oil Nutrition 0.000 description 3
- 239000003240 coconut oil Substances 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000004898 kneading Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000010445 mica Substances 0.000 description 3
- 229910052618 mica group Inorganic materials 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000003760 tallow Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 2
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 229920000178 Acrylic resin Polymers 0.000 description 2
- 239000004925 Acrylic resin Substances 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 2
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004734 Polyphenylene sulfide Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000008199 coating composition Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 229920000591 gum Polymers 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 239000001023 inorganic pigment Substances 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 2
- 239000012860 organic pigment Substances 0.000 description 2
- 229960000969 phenyl salicylate Drugs 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000069 polyphenylene sulfide Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 229920002050 silicone resin Polymers 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000011069 sorbitan monooleate Nutrition 0.000 description 2
- 239000001593 sorbitan monooleate Substances 0.000 description 2
- 229940035049 sorbitan monooleate Drugs 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 238000003856 thermoforming Methods 0.000 description 2
- 229920005992 thermoplastic resin Polymers 0.000 description 2
- 229920001187 thermosetting polymer Polymers 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 2
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- RUHCWQAFCGVQJX-RVWHZBQESA-N (3s,8s,9s,10r,13r,14s,17r)-3-hydroxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-1-one Chemical compound C1C=C2C[C@H](O)CC(=O)[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RUHCWQAFCGVQJX-RVWHZBQESA-N 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- CWLGEPSKQDNHIO-JOBJLJCHSA-N (e)-n-[(e)-benzylideneamino]-1-phenylmethanimine Chemical compound C=1C=CC=CC=1/C=N/N=C/C1=CC=CC=C1 CWLGEPSKQDNHIO-JOBJLJCHSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- DXMNMEWATKSWOT-UHFFFAOYSA-N 1-[2,3-di(nonyl)phenoxy]-2,3-di(nonyl)benzene Chemical compound CCCCCCCCCC1=CC=CC(OC=2C(=C(CCCCCCCCC)C=CC=2)CCCCCCCCC)=C1CCCCCCCCC DXMNMEWATKSWOT-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- ZXNAIPHYBVMMPY-KTKRTIGZSA-N 1-erucoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OCC(O)CO ZXNAIPHYBVMMPY-KTKRTIGZSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- JWKSQNWLEIABLH-UHFFFAOYSA-N 1-octan-2-yloxydodecane Chemical compound CCCCCCCCCCCCOC(C)CCCCCC JWKSQNWLEIABLH-UHFFFAOYSA-N 0.000 description 1
- QQXJNLYVPPBERR-UHFFFAOYSA-N 1-phenyldecan-1-one Chemical compound CCCCCCCCCC(=O)C1=CC=CC=C1 QQXJNLYVPPBERR-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- XATHTZNVYDUDGS-UHFFFAOYSA-N 2-octadecylpropane-1,2,3-triol Chemical compound CCCCCCCCCCCCCCCCCCC(O)(CO)CO XATHTZNVYDUDGS-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- ZUACFBHNVKYJFQ-UHFFFAOYSA-N 2-tert-butyl-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(C(C)(C)C)C(=O)C1=CC=CC=C1 ZUACFBHNVKYJFQ-UHFFFAOYSA-N 0.000 description 1
- MSPJNHHBNOLHOC-UHFFFAOYSA-N 3,3-dimethylcyclopropane-1,2-dicarboxylic acid Chemical compound CC1(C)C(C(O)=O)C1C(O)=O MSPJNHHBNOLHOC-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- JOKBLKCZHGIRNO-UHFFFAOYSA-N 5-benzoyl-2-hydroxybenzoic acid Chemical compound C1=C(O)C(C(=O)O)=CC(C(=O)C=2C=CC=CC=2)=C1 JOKBLKCZHGIRNO-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- RDBLNMQDEWOUIB-UHFFFAOYSA-N 5-methyl-2-phenyl-1,3-benzoxazole Chemical compound N=1C2=CC(C)=CC=C2OC=1C1=CC=CC=C1 RDBLNMQDEWOUIB-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-M 5-oxo-L-prolinate Chemical compound [O-]C(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-M 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241001237961 Amanita rubescens Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000012137 Atriplex confertifolia Nutrition 0.000 description 1
- 244000266618 Atriplex confertifolia Species 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
- 244000061408 Eugenia caryophyllata Species 0.000 description 1
- 241000975394 Evechinus chloroticus Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- QZXSMBBFBXPQHI-UHFFFAOYSA-N N-(dodecanoyl)ethanolamine Chemical compound CCCCCCCCCCCC(=O)NCCO QZXSMBBFBXPQHI-UHFFFAOYSA-N 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000010678 Paulownia tomentosa Nutrition 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229930182556 Polyacetal Natural products 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004697 Polyetherimide Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 244000028344 Primula vulgaris Species 0.000 description 1
- 235000016311 Primula vulgaris Nutrition 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229910052581 Si3N4 Inorganic materials 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- NRTOMJZYCJJWKI-UHFFFAOYSA-N Titanium nitride Chemical compound [Ti]#N NRTOMJZYCJJWKI-UHFFFAOYSA-N 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 244000111306 Torreya nucifera Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- KILYNHHCRKVDRU-UHFFFAOYSA-N [S].C1CC2(C)C(=O)CC1C2(C)C Chemical compound [S].C1CC2(C)C(=O)CC1C2(C)C KILYNHHCRKVDRU-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- XECAHXYUAAWDEL-UHFFFAOYSA-N acrylonitrile butadiene styrene Chemical compound C=CC=C.C=CC#N.C=CC1=CC=CC=C1 XECAHXYUAAWDEL-UHFFFAOYSA-N 0.000 description 1
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- ARCGXLSVLAOJQL-UHFFFAOYSA-N anhydrous trimellitic acid Natural products OC(=O)C1=CC=C(C(O)=O)C(C(O)=O)=C1 ARCGXLSVLAOJQL-UHFFFAOYSA-N 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 108010045569 atelocollagen Proteins 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000002199 base oil Substances 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- PMHQVHHXPFUNSP-UHFFFAOYSA-M copper(1+);methylsulfanylmethane;bromide Chemical compound Br[Cu].CSC PMHQVHHXPFUNSP-UHFFFAOYSA-M 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- FGEUKKGODAGXOD-FMIVXFBMSA-N cyclohexyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound C1=CC(OC)=CC=C1\C=C\C(=O)OC1CCCCC1 FGEUKKGODAGXOD-FMIVXFBMSA-N 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- JZKFHQMONDVVNF-UHFFFAOYSA-N dodecyl sulfate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCOS(O)(=O)=O JZKFHQMONDVVNF-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- KCDAMWRCUXGACP-DHZHZOJOSA-N ethyl (e)-2-cyano-3-phenylprop-2-enoate Chemical compound CCOC(=O)C(\C#N)=C\C1=CC=CC=C1 KCDAMWRCUXGACP-DHZHZOJOSA-N 0.000 description 1
- XRLCQRMNGQRGOC-MDZDMXLPSA-N ethyl (e)-3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CC=C(C(C)C)C=C1C(C)C XRLCQRMNGQRGOC-MDZDMXLPSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- TUKWPCXMNZAXLO-UHFFFAOYSA-N ethyl 2-nonylsulfanyl-4-oxo-1h-pyrimidine-6-carboxylate Chemical compound CCCCCCCCCSC1=NC(=O)C=C(C(=O)OCC)N1 TUKWPCXMNZAXLO-UHFFFAOYSA-N 0.000 description 1
- XCRHYAQWBYDRGV-UHFFFAOYSA-N ethyl 3-(4-propan-2-ylphenyl)prop-2-enoate Chemical compound CCOC(=O)C=CC1=CC=C(C(C)C)C=C1 XCRHYAQWBYDRGV-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229940072117 fennel extract Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000013007 heat curing Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 229940074358 magnesium ascorbate Drugs 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AIOKQVJVNPDJKA-ZZMNMWMASA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-olate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] AIOKQVJVNPDJKA-ZZMNMWMASA-L 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229960004665 menthyl salicylate Drugs 0.000 description 1
- SJOXEWUZWQYCGL-DVOMOZLQSA-N menthyl salicylate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-DVOMOZLQSA-N 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- YKWKFUUHPFWRNV-UHFFFAOYSA-N methyl 3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound COC(=O)C=CC1=CC=C(C(C)C)C=C1C(C)C YKWKFUUHPFWRNV-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- MJVGBKJNTFCUJM-UHFFFAOYSA-N mexenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(C)C=C1 MJVGBKJNTFCUJM-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- UVPGECJLXBGLDW-UHFFFAOYSA-N octadecan-7-ol Chemical compound CCCCCCCCCCCC(O)CCCCCC UVPGECJLXBGLDW-UHFFFAOYSA-N 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- ZPIRTVJRHUMMOI-UHFFFAOYSA-N octoxybenzene Chemical compound CCCCCCCCOC1=CC=CC=C1 ZPIRTVJRHUMMOI-UHFFFAOYSA-N 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- ZBVQEUUTPTVMHY-UHFFFAOYSA-N phenyl-(2-phenylphenyl)methanone Chemical compound C=1C=CC=C(C=2C=CC=CC=2)C=1C(=O)C1=CC=CC=C1 ZBVQEUUTPTVMHY-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920001225 polyester resin Polymers 0.000 description 1
- 239000004645 polyester resin Substances 0.000 description 1
- 229920001601 polyetherimide Polymers 0.000 description 1
- 229920000120 polyethyl acrylate Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920013636 polyphenyl ether polymer Polymers 0.000 description 1
- 229920001955 polyphenylene ether Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000001819 propan-2-yl (E)-3-phenylprop-2-enoate Substances 0.000 description 1
- XATKDVHSLQMHSY-RMKNXTFCSA-N propan-2-yl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound COC1=CC=C(\C=C\C(=O)OC(C)C)C=C1 XATKDVHSLQMHSY-RMKNXTFCSA-N 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- WZXKPNYMUZGZIA-RMKNXTFCSA-N propyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound CCCOC(=O)\C=C\C1=CC=C(OC)C=C1 WZXKPNYMUZGZIA-RMKNXTFCSA-N 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229940043131 pyroglutamate Drugs 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 238000013040 rubber vulcanization Methods 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- SJOXEWUZWQYCGL-UHFFFAOYSA-N salicylic acid menthyl ester Natural products CC(C)C1CCC(C)CC1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-UHFFFAOYSA-N 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 229920003179 starch-based polymer Polymers 0.000 description 1
- 239000004628 starch-based polymer Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- KWXLCDNSEHTOCB-UHFFFAOYSA-J tetrasodium;1,1-diphosphonatoethanol Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P(=O)([O-])C(O)(C)P([O-])([O-])=O KWXLCDNSEHTOCB-UHFFFAOYSA-J 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- SVETUDAIEHYIKZ-IUPFWZBJSA-N tris[(z)-octadec-9-enyl] phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCCOP(=O)(OCCCCCCCC\C=C/CCCCCCCC)OCCCCCCCC\C=C/CCCCCCCC SVETUDAIEHYIKZ-IUPFWZBJSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 150000003752 zinc compounds Chemical class 0.000 description 1
- 229910052984 zinc sulfide Inorganic materials 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229910000859 α-Fe Inorganic materials 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/0245—Specific shapes or structures not provided for by any of the groups of A61K8/0241
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G9/00—Compounds of zinc
- C01G9/02—Oxides; Hydroxides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/20—Oxides; Hydroxides
- C08K3/22—Oxides; Hydroxides of metals
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D5/00—Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced; Filling pastes
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D7/00—Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
- C09D7/40—Additives
- C09D7/60—Additives non-macromolecular
- C09D7/61—Additives non-macromolecular inorganic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
- C01P2002/72—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
- C01P2002/74—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by peak-intensities or a ratio thereof only
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
- C01P2002/76—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by a space-group or by other symmetry indications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/01—Particle morphology depicted by an image
- C01P2004/04—Particle morphology depicted by an image obtained by TEM, STEM, STM or AFM
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/60—Particles characterised by their size
- C01P2004/61—Micrometer sized, i.e. from 1-100 micrometer
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Wood Science & Technology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Geometry (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Cosmetics (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Paints Or Removers (AREA)
Description
本発明は、放射状酸化亜鉛粒子、その製造方法、放熱性フィラー及び化粧料に関するものである。 The present invention relates to radial zinc oxide particles, a method for producing the same, a heat dissipating filler, and a cosmetic.
酸化亜鉛粒子は、放熱特性等の性質を有するものであることから、電気分野において使用される樹脂組成物、グリース組成物、塗料組成物等において、放熱性フィラー等として使用することが知られている。 Since zinc oxide particles have properties such as heat dissipation characteristics, they are known to be used as heat dissipating fillers in resin compositions, grease compositions, paint compositions, etc. used in the electrical field. Yes.
一方、放射状の酸化亜鉛としては、特許文献1〜3に記載されたようなものが知られている。特許文献1には、酸化亜鉛のウィスカー膜の製造方法が記載されている。更にこのようにして製造された酸化亜鉛膜の結晶形状が示されており、これらは放射状の形状を有している。しかし、溶液を長時間放置することによって結晶を析出させるものであることから、製造効率が低下してしまうという問題がある。更に、酸化亜鉛粒子を製造することに関する具体的な製造方法は記載されていない。また、粒子の中心に位置する六角柱部分とその周りに放射状に成長した部分とで構成された放射状酸化亜鉛粒子を得ることはできない。 On the other hand, as the radial zinc oxide, those described in Patent Documents 1 to 3 are known. Patent Document 1 describes a method for producing a zinc oxide whisker film. Furthermore, the crystal shape of the zinc oxide film thus produced is shown, and these have a radial shape. However, since the crystal is precipitated by leaving the solution for a long time, there is a problem that the production efficiency is lowered. Furthermore, a specific production method relating to producing zinc oxide particles is not described. Moreover, the radial zinc oxide particle comprised by the hexagonal column part located in the center of particle | grains and the part grown radially around it cannot be obtained.
特許文献2及び3には、放射状の酸化亜鉛が記載されている。しかし、特許文献2には化粧料への使用が記載されているのみであり、放熱性フィラー等の使用は記載されていない。また、粒子の中心に位置する六角柱部分とその周りに放射状に成長した部分とで構成された放射状酸化亜鉛粒子を得ることはできない。 Patent Documents 2 and 3 describe radial zinc oxide. However, Patent Document 2 only describes use for cosmetics, and does not describe use of a heat-dissipating filler or the like. Moreover, the radial zinc oxide particle comprised by the hexagonal column part located in the center of particle | grains and the part grown radially around it cannot be obtained.
一方、特許文献3の製造方法においては、亜鉛化合物とアミン化合物を混合した水溶液のpHを調整することで沈殿物を析出させ、その水溶液を加熱することで酸化亜鉛を得る方法が記載されている。しかし、このような方法によって、粒子の中心に位置する六角柱部分とその周りに放射状に成長した部分とで構成された放射状酸化亜鉛粒子を得ることはできない。 On the other hand, in the production method of Patent Document 3, a method is described in which a precipitate is precipitated by adjusting the pH of an aqueous solution in which a zinc compound and an amine compound are mixed, and zinc oxide is obtained by heating the aqueous solution. . However, by such a method, it is not possible to obtain radial zinc oxide particles composed of a hexagonal column portion located at the center of the particle and a portion grown radially around the hexagonal column portion.
本発明は上記に鑑み、粒子の中心に位置する六角柱部分とその周りに放射状に成長した部分とで構成された放射状酸化亜鉛粒子、短時間かつ少ない工程で安価な材料のみを使用して効率よく放射状酸化亜鉛粒子を製造する方法、そのような方法によって製造された放射状酸化亜鉛粒子及びそのような放射状酸化亜鉛粒子からなる放熱性フィラー、化粧料を提供することを目的とするものである。 In view of the above, the present invention is efficient by using only radial zinc oxide particles composed of a hexagonal column portion located at the center of the particle and a portion grown radially around the particle, using only inexpensive materials in a short time and with fewer steps. It is an object of the present invention to provide a method for producing radial zinc oxide particles well, a radial zinc oxide particle produced by such a method, a heat dissipating filler comprising such a radial zinc oxide particle, and a cosmetic.
本発明は、酢酸亜鉛とアンモニア水を混合して水酸化亜鉛を得る工程(1)と、工程(1)により得られた水酸化亜鉛をアンモニア水に溶解する工程(2)と、工程(2)により得られた亜鉛アンミン錯体水溶液を瞬間的に90℃以上に加熱した水または90℃以上に加熱した親水性溶媒に亜鉛アンミン錯体水溶液を添加して熱分解する工程(3)を有することを特徴とする放射状酸化亜鉛粒子の製造方法でもある。
The present invention includes a step (1) of obtaining zinc hydroxide by mixing zinc acetate and aqueous ammonia, a step (2) of dissolving zinc hydroxide obtained in step (1) in aqueous ammonia, and a step (2). A step (3) of adding the zinc ammine complex aqueous solution to water heated instantaneously to 90 ° C. or higher or a hydrophilic solvent heated to 90 ° C. or higher and thermally decomposing the resulting solution. It is also a featured method of producing radial zinc oxide particles .
本発明の放射状酸化亜鉛粒子の製造方法によって、安価な原料を使用して効率よく放射状酸化亜鉛粒子を得ることができる。更に、このような方法によって得られた放射状酸化亜鉛粒子は、放熱性フィラーとして使用した場合に、優れた効果を発揮するものである。 By the method for producing radial zinc oxide particles of the present invention, radial zinc oxide particles can be efficiently obtained using an inexpensive raw material. Furthermore, the radial zinc oxide particles obtained by such a method exhibit excellent effects when used as a heat-dissipating filler.
以下に、本発明を詳細に説明する。
本発明の放射状酸化亜鉛粒子は、図14に示したように、粒子の中心に位置する六角柱部分とその周りに放射状に成長した部分とで構成された放射状酸化亜鉛粒子である。従来、このような形状に着目した放射状酸化亜鉛粒子はなかった。本発明は、特徴的な放射状形状に由来する優れた熱伝導性、使用感等を示す酸化亜鉛粒子を提供するものである。The present invention is described in detail below.
As shown in FIG. 14, the radial zinc oxide particles of the present invention are radial zinc oxide particles composed of a hexagonal column portion located at the center of the particle and a portion grown radially around the hexagonal column portion. Conventionally, there has been no radial zinc oxide particle focusing on such a shape. The present invention provides zinc oxide particles exhibiting excellent thermal conductivity, usability, etc. derived from a characteristic radial shape.
本発明の放射状酸化亜鉛粒子は、平均粒子径が1〜100μmであることが好ましい。本発明において、平均粒子径は、走査型電子顕微鏡(SEM、JSM−5600、日本電子社製)写真の1000〜5000倍の視野での定方向径(粒子を挟む一定方向の二本の平行線の間隔;画像上のどのような形状の粒子についても、一定方向で測定した)で定義される粒子径(μm)であって、SEM写真内の粒子100個の定方向径を計測し、その累積分布の平均値を求めたものである。上記範囲内の粒子径のものとすることは、放熱材料として用いた場合に熱伝導率を充分に高めることができ、また、化粧料として肌に塗布した場合には滑らかな感触を得ることができるという観点から好ましいものである。 The radial zinc oxide particles of the present invention preferably have an average particle diameter of 1 to 100 μm. In the present invention, the average particle diameter is a fixed direction diameter (two parallel lines in a fixed direction across the particle) in a field of view of 1000 to 5000 times that of a scanning electron microscope (SEM, JSM-5600, manufactured by JEOL Ltd.) photograph. The particle diameter (μm) defined by the particle interval (measured in a certain direction for particles of any shape on the image), and the constant direction diameter of 100 particles in the SEM photograph was measured. The average value of the cumulative distribution is obtained. Having a particle size within the above range can sufficiently increase the thermal conductivity when used as a heat dissipation material, and can provide a smooth feel when applied to the skin as a cosmetic. It is preferable from the viewpoint that it can be performed.
本発明の放射状酸化亜鉛粒子は、X線回折装置により測定した酸化亜鉛の板状方向;(002)面の強度と酸化亜鉛の柱状方向;(100)面の強度の比;I(002)/I(100)が0.4〜1.0であることが好ましい。このようなパラメータは、酸化亜鉛粒子の板状方向あるいは柱状方向への配向性の程度を表わすものである。よって、この値が0.4〜1.0であることは、一定方向に配向しやすい酸化亜鉛粒子ではなく、どの向きに対しても等価に存在する酸化亜鉛粒子であることを意味する。このような酸化亜鉛粒子の中でも、特に本発明のような放射状酸化亜鉛粒子においては、例えば樹脂と混練して成型体を作成した場合、その成型体の内部で最小限の占有体積にて粒子同士が連結することになる。このように最小限の占有体積で粒子同士が連結することによって、球状、棒状、針状、板状等の形状を有する酸化亜鉛粒子よりも少ない配合量でも熱伝導のパーコレーションを形成し、より効率的に熱伝導を高めることができるという点において特に好ましいものである。 The radial zinc oxide particles of the present invention have a plate-like direction of zinc oxide measured by an X-ray diffractometer; a ratio of (002) plane strength and zinc oxide columnar direction; (100) plane strength; I (002) / It is preferable that I (100) is 0.4 to 1.0. Such a parameter represents the degree of orientation of the zinc oxide particles in the plate-like direction or the columnar direction. Therefore, this value of 0.4 to 1.0 means that the zinc oxide particles are not easily oriented in a certain direction but equivalent to any direction. Among such zinc oxide particles, particularly in the case of the radial zinc oxide particles as in the present invention, for example, when a molded body is prepared by kneading with a resin, the particles are formed with a minimum occupied volume inside the molded body. Will be linked. By connecting particles with a minimum occupied volume in this way, heat conduction percolation is formed even with a smaller amount than zinc oxide particles having a spherical shape, rod shape, needle shape, plate shape, etc., and more efficient. In particular, it is particularly preferable in that heat conduction can be enhanced.
上記I(002)/I(100)は、銅管球をもつX線回折装置UltimaIII(リガク社製)により分析した結果を示したものである。六方晶ウルツ型酸化亜鉛粒子のX線回折パターンにおける酸化亜鉛の(002)面の強度;I(002)の値を、酸化亜鉛の(100)面の強度;I(100)の値で除した値である。 The above I (002) / I (100) shows the result of analysis by an X-ray diffractometer Ultima III (manufactured by Rigaku Corporation) having a copper tube. The intensity of (002) plane of zinc oxide in the X-ray diffraction pattern of hexagonal wurtzite zinc oxide particles; the value of I (002) divided by the intensity of (100) plane of zinc oxide; the value of I (100) Value.
本発明の放射状酸化亜鉛粒子の製造方法としては特に限定されないが、例えば、酢酸亜鉛とアンモニア水を混合して水酸化亜鉛を得る工程(1)と、工程(1)により得られた水酸化亜鉛をアンモニア水に溶解する工程(2)と、工程(2)により得られた亜鉛アンミン錯体水溶液を瞬間的に90℃以上で熱分解する工程(3)を有する方法等を挙げることができる。このような工程によって、簡便に放射状酸化亜鉛粒子を得ることができる。このような放射状酸化亜鉛粒子の製造方法も本発明の一つである。 Although it does not specifically limit as a manufacturing method of the radial zinc oxide particle | grains of this invention, For example, the zinc hydroxide obtained by mixing the zinc acetate and ammonia water to obtain zinc hydroxide, and the zinc hydroxide obtained by the process (1) And a step (2) in which the aqueous solution of zinc ammine complex obtained in step (2) is instantaneously pyrolyzed at 90 ° C. or higher. By such steps, radial zinc oxide particles can be easily obtained. A method for producing such radial zinc oxide particles is also one aspect of the present invention.
本発明の放射状酸化亜鉛粒子の製造方法における工程(1)は、酢酸亜鉛とアンモニア水を混合して水酸化亜鉛を得る工程である。このような水酸化亜鉛の製造方法は当業者に公知の任意の方法によっても行うことができるが、例えば、酢酸亜鉛水溶液とアンモニア水とを混合する方法等を挙げることができる。反応温度は、5〜100℃で行うことができ、反応時間は0.5〜12時間で行うことができる。酢酸亜鉛とアンモニア水とを混合すると、水酸化亜鉛は水に不溶の沈殿として析出する。 Step (1) in the method for producing radial zinc oxide particles of the present invention is a step of obtaining zinc hydroxide by mixing zinc acetate and aqueous ammonia. Such a method for producing zinc hydroxide can be carried out by any method known to those skilled in the art, and examples thereof include a method of mixing an aqueous zinc acetate solution and aqueous ammonia. The reaction temperature can be 5 to 100 ° C., and the reaction time can be 0.5 to 12 hours. When zinc acetate and aqueous ammonia are mixed, zinc hydroxide precipitates as a precipitate insoluble in water.
本発明においては、亜鉛源となる原料として酢酸亜鉛を使用するものである。これによって、本発明の酸化亜鉛粒子の前駆体となる斜方晶単相のε−水酸化亜鉛の粒子が得られ、水酸化亜鉛純度の高いε−水酸化亜鉛粒子が選択的に得られるという点で好ましい結果が得られる。 In the present invention, zinc acetate is used as a raw material to be a zinc source. As a result, orthorhombic single-phase ε-zinc hydroxide particles, which are precursors of the zinc oxide particles of the present invention, are obtained, and ε-zinc hydroxide particles having high zinc hydroxide purity are selectively obtained. A favorable result is obtained with respect to this point.
上記工程(1)において、酢酸亜鉛水溶液を使用する場合の濃度は、0.1〜2mol/lであることが好ましく、0.3〜1.5mol/lであることが更に好ましい。アンモニア水の濃度としては特に限定されないが、0.1〜16mol/lであることが好ましく、0.5〜10mol/lであることが更に好ましい。上記工程(1)においては、酢酸亜鉛に対し当量以上のアンモニアを混合して反応させることが好ましい。 In the step (1), the concentration in the case of using an aqueous zinc acetate solution is preferably 0.1 to 2 mol / l, and more preferably 0.3 to 1.5 mol / l. Although it does not specifically limit as a density | concentration of aqueous ammonia, It is preferable that it is 0.1-16 mol / l, and it is still more preferable that it is 0.5-10 mol / l. In the said process (1), it is preferable to mix and react ammonia more than an equivalent with respect to zinc acetate.
得られた水酸化亜鉛は、水中に沈澱又は分散した状態で途中で反応を停止させることなくそのままアンモニア水を添加し続けることで工程(2)を行ってもよいし、工程(1)において略当量のアンモニア水を添加した後、必要に応じて濃縮、希釈等の処理を行った後で工程(2)に供してもよい。 The obtained zinc hydroxide may be subjected to the step (2) by continuing to add ammonia water as it is without stopping the reaction in the middle of being precipitated or dispersed in water. After adding an equivalent amount of aqueous ammonia, it may be subjected to a treatment such as concentration, dilution or the like, if necessary, and then subjected to step (2).
また、上記工程(1)によって得られた水酸化亜鉛は、濾過・水洗を行うことによって、不純物の除去を行った後に工程(2)に供してもよい。このようにすることで、工程(1)によって生じた不純物が得られた酸化亜鉛粒子中に残存することを抑制することができ、焼成工程を経ることなく、酸化亜鉛純度が高い放射状酸化亜鉛粒子を得ることができる点でより好ましい。上記濾過・水洗を行う方法は特に限定されず、通常の方法によって行うことができる。 Further, the zinc hydroxide obtained by the above step (1) may be subjected to the step (2) after removing impurities by filtering and washing with water. By doing in this way, it can suppress that the impurity produced by the process (1) remains in the obtained zinc oxide particle, and the radial zinc oxide particle with high zinc oxide purity without passing through a baking process. Is more preferable in that it can be obtained. The method of performing said filtration and water washing is not specifically limited, It can carry out by a normal method.
工程(2)は、上記工程(1)によって得られた水酸化亜鉛を、アンモニア水に溶解することによって、亜鉛アンミン錯体水溶液を得る工程である。水酸化亜鉛に更に、アンモニア水を添加すると、[Zn(NH3)4 2+]の一般式で表わされるテトラアンミン亜鉛イオン(すなわち、亜鉛アンミン錯体)の水溶液が得られる。Step (2) is a step of obtaining a zinc ammine complex aqueous solution by dissolving the zinc hydroxide obtained in the above step (1) in aqueous ammonia. When ammonia water is further added to zinc hydroxide, an aqueous solution of tetraammine zinc ions (that is, zinc ammine complex) represented by the general formula [Zn (NH 3 ) 4 2 + ] is obtained.
このような工程(2)の反応は、例えば、水分を除去した水酸化亜鉛又は0.001〜500g/lの濃度で水中に分散させた水酸化亜鉛に対してアンモニア水を添加する方法によっても行うことができる。このような工程によって、水に不溶であった水酸化亜鉛が水に溶解し、[Zn(NH3)4 2+]が形成される。The reaction in the step (2) can be performed by, for example, adding ammonia water to zinc hydroxide from which water has been removed or zinc hydroxide dispersed in water at a concentration of 0.001 to 500 g / l. It can be carried out. By such a process, zinc hydroxide that was insoluble in water is dissolved in water, and [Zn (NH 3 ) 4 2 + ] is formed.
このような反応に際しては、5〜50℃において、0.1〜12時間攪拌することによって行うことができる。使用するアンモニア水の濃度は、0.1〜16mol/lであることが好ましく、0.5〜10mol/lであることが更に好ましい。また、アンモニアの添加量は、亜鉛量に対してモル数として5倍以上となる量であることが好ましい。 Such a reaction can be carried out by stirring at 5 to 50 ° C. for 0.1 to 12 hours. The concentration of the aqueous ammonia used is preferably 0.1 to 16 mol / l, and more preferably 0.5 to 10 mol / l. Moreover, it is preferable that the addition amount of ammonia is the amount which becomes 5 times or more as a mole number with respect to the zinc amount.
上記工程(2)を行った後、必要に応じて希釈、濃縮等を行うことによって、亜鉛アンミン錯体の濃度を調整してもよい。また、限外濾過等の方法で系内に存在する不純物を除去する等してもよい。 After performing the said process (2), you may adjust the density | concentration of a zinc ammine complex by performing dilution, concentration, etc. as needed. Further, impurities existing in the system may be removed by a method such as ultrafiltration.
上記工程(3)は、上記工程(2)によって得られた亜鉛アンミン錯体[Zn(NH3)4 2+]を熱分解して、酸化亜鉛粒子を得る工程である。特許文献1等に記載されたテトラヒドロキシ亜鉛イオン[Zn(OH)4 2-]からの酸化亜鉛の製造は、基材上にテトラヒドロキシ亜鉛イオン溶液を塗布して基材表面に酸化亜鉛を析出させるものであるが、このような方法は薄膜状の酸化亜鉛しか形成させることができない。更に、特許文献2、3に記載されたような放射状酸化亜鉛の製造方法は、亜鉛アンミン錯体からの熱分解によって酸化亜鉛粒子を得るものではないため、得られた酸化亜鉛粒子は本発明の方法によって得られた放射状酸化亜鉛粒子とは異なるものである。The step (3) is a step of obtaining zinc oxide particles by thermally decomposing the zinc ammine complex [Zn (NH 3 ) 4 2+ ] obtained in the step (2). The production of zinc oxide from tetrahydroxyzinc ions [Zn (OH) 4 2− ] described in Patent Document 1 and the like is performed by applying a tetrahydroxyzinc ion solution on the substrate and depositing zinc oxide on the substrate surface. However, such a method can form only thin-film zinc oxide. Furthermore, since the manufacturing method of radial zinc oxide as described in Patent Documents 2 and 3 does not obtain zinc oxide particles by thermal decomposition from a zinc ammine complex, the obtained zinc oxide particles are the method of the present invention. It is different from the radial zinc oxide particles obtained by.
これらの従来の製造方法に比べて、本発明の放射状酸化亜鉛粒子の製造方法は、安価な原料を使用していることなどの点で好ましいものである。 Compared to these conventional production methods, the production method of the radial zinc oxide particles of the present invention is preferable in that an inexpensive raw material is used.
上記工程(3)においては、亜鉛アンミン錯体の濃度は水酸化亜鉛に換算した場合に0.1〜2mol/lであることが好ましく、0.2〜1mol/lであることが更に好ましい。 In the step (3), the concentration of the zinc ammine complex is preferably 0.1 to 2 mol / l, more preferably 0.2 to 1 mol / l, when converted to zinc hydroxide.
また、上記工程(3)は、亜鉛アンミン錯体を瞬間的に90℃以上で熱分解する工程である。瞬間的に熱分解を進行させることにより、特徴的な形状を有する本発明の放射状酸化亜鉛粒子を選択的に得ることができる。また、熱分解温度を90℃以上とすることで、速やかに熱分解が進行し、目的とする放射状酸化亜鉛粒子を均一な状態で安定して得ることができる。瞬間的に熱分解するとは、1秒から10分という短い時間で亜鉛アンミン錯体の熱による分解を進行させることを指し、例えば、90℃以上に加熱した水、または90℃以上に加熱したエチレングリコール等の親水性溶媒に上記亜鉛アンミン錯体水溶液を添加する方法等を挙げることができる。このような方法においては、添加する亜鉛アンミン錯体水溶液の体積に対して2倍以上の体積の加熱した水、または添加する亜鉛アンミン錯体水溶液の体積に対して2倍以上の体積の加熱したエチレングリコール等の親水性溶媒に添加することで、溶液の温度低下を殆ど生じることなく、効率よく熱分解を行うことができる点で好ましい。 Moreover, the said process (3) is a process of thermally decomposing a zinc ammine complex instantaneously at 90 degreeC or more. By causing the thermal decomposition to proceed instantaneously, the radial zinc oxide particles of the present invention having a characteristic shape can be selectively obtained. Further, by setting the thermal decomposition temperature to 90 ° C. or higher, the thermal decomposition proceeds rapidly, and the desired radial zinc oxide particles can be stably obtained in a uniform state. Instantaneous thermal decomposition refers to the thermal decomposition of a zinc ammine complex in a short time of 1 second to 10 minutes. For example, water heated to 90 ° C or higher, or ethylene glycol heated to 90 ° C or higher And a method of adding the zinc ammine complex aqueous solution to a hydrophilic solvent such as In such a method, heated water having a volume more than twice the volume of the added zinc ammine complex aqueous solution or heated ethylene glycol having a volume more than twice the volume of the added zinc ammine complex aqueous solution. By adding to a hydrophilic solvent such as the above, it is preferable in that the thermal decomposition can be carried out efficiently with almost no decrease in the temperature of the solution.
これらの亜鉛アンミン錯体濃度、添加時間、熱分解温度等を調整することによって、得られる放射状酸化亜鉛粒子の粒子径、粒子形状等をコントロールすることができる。 By adjusting the concentration of these zinc ammine complexes, addition time, thermal decomposition temperature, and the like, the particle diameter, particle shape, and the like of the obtained radial zinc oxide particles can be controlled.
本発明は上述した工程(1)〜(3)からなる放射状酸化亜鉛粒子の製造方法によって得られた放射状酸化亜鉛粒子でもある。このような放射状酸化亜鉛粒子は、上述の物性を有することが好ましい。 This invention is also the radial zinc oxide particle obtained by the manufacturing method of the radial zinc oxide particle which consists of process (1)-(3) mentioned above. Such radial zinc oxide particles preferably have the above-described physical properties.
本発明の放射状酸化亜鉛粒子を放熱性フィラーとして使用する場合、単独で使用するものであっても、粒子径が異なる放熱性フィラーと組み合わせて使用するものであってもよい。組み合わせて使用することができる放熱性フィラーとしては特に限定されず、例えば、他の形状を有する酸化亜鉛、酸化マグネシウム、酸化チタン、酸化アルミニウム等の金属酸化物、窒化アルミニウム、窒化ホウ素、炭化ケイ素、窒化ケイ素、窒化チタン、金属シリコン、ダイヤモンド等を挙げることができる。 When the radial zinc oxide particles of the present invention are used as a heat dissipating filler, they may be used alone or in combination with heat dissipating fillers having different particle diameters. The heat dissipating filler that can be used in combination is not particularly limited. For example, metal oxides such as zinc oxide, magnesium oxide, titanium oxide, and aluminum oxide having other shapes, aluminum nitride, boron nitride, silicon carbide, Examples thereof include silicon nitride, titanium nitride, metal silicon, and diamond.
本発明の放射状酸化亜鉛粒子は、より粒子径が小さい酸化亜鉛粒子及び他の放熱性フィラーと組み合わせて使用することで、より優れた放熱性能を得ることができる。組み合わせて使用する粒子径が小さい酸化亜鉛粒子は、球状、針状、棒状、板状等の形状を有するものであることが好ましい。 When the radial zinc oxide particles of the present invention are used in combination with zinc oxide particles having a smaller particle diameter and other heat dissipating fillers, more excellent heat dissipating performance can be obtained. The zinc oxide particles having a small particle diameter used in combination are preferably those having a spherical shape, a needle shape, a rod shape, a plate shape, or the like.
上記放射状酸化亜鉛粒子を放熱性フィラーとして使用する場合、樹脂と混合した放熱性樹脂組成物として使用することができる。この場合、使用する樹脂は、熱可塑性樹脂であっても熱硬化性樹脂であっても良く、エポキシ樹脂、フェノール樹脂、ポリフェニレンサルファイド(PPS)樹脂、ポリエステル系樹脂、ポリアミド、ポリイミド、ポリスチレン、ポリエチレン、ポリプロピレン、ポリ塩化ビニル、ポリ塩化ビニリデン、フッ素樹脂、ポリメタクリル酸メチル、エチレン・アクリル酸エチル共重合体(EEA)樹脂、ポリカーボネート、ポリウレタン、ポリアセタール、ポリフェニレンエーテル、ポリエーテルイミド、アクリロニトリル−ブタジエン−スチレン共重合体(ABS)樹脂、液晶樹脂(LCP)、シリコーン樹脂、アクリル樹脂等の樹脂を挙げることができる。 When using the said radial zinc oxide particle as a heat dissipation filler, it can be used as a heat dissipation resin composition mixed with resin. In this case, the resin used may be a thermoplastic resin or a thermosetting resin, and an epoxy resin, a phenol resin, a polyphenylene sulfide (PPS) resin, a polyester resin, polyamide, polyimide, polystyrene, polyethylene, Polypropylene, polyvinyl chloride, polyvinylidene chloride, fluororesin, polymethyl methacrylate, ethylene / ethyl acrylate copolymer (EEA) resin, polycarbonate, polyurethane, polyacetal, polyphenylene ether, polyetherimide, acrylonitrile-butadiene-styrene Examples of the resin include polymer (ABS) resin, liquid crystal resin (LCP), silicone resin, and acrylic resin.
本発明の放熱性樹脂組成物は、(a)熱可塑性樹脂と上記放射状酸化亜鉛粒子とを溶融状態で混練することによって得られた熱成型用の樹脂組成物、(b)熱硬化性樹脂と上記放射状酸化亜鉛粒子とを混練後、加熱硬化させることによって得られた樹脂組成物、(c)樹脂溶液又は分散液中に上記放射状酸化亜鉛粒子を分散させた塗料用の樹脂組成物であっても良い。 The heat-dissipating resin composition of the present invention comprises: (a) a thermoforming resin composition obtained by kneading a thermoplastic resin and the radial zinc oxide particles in a molten state; and (b) a thermosetting resin. A resin composition obtained by kneading the radial zinc oxide particles and then heat-curing, (c) a resin composition for paint in which the radial zinc oxide particles are dispersed in a resin solution or dispersion. Also good.
本発明の放熱性樹脂組成物中の上記放射状酸化亜鉛粒子の配合量は、目的とする放熱性能や樹脂組成物の硬度等、樹脂組成物の性能に合わせて任意に決定することができる。上記放射状酸化亜鉛粒子の放熱性能を十分に発現させるためには、樹脂組成物中の固形分全量に対して10体積%以上、より好ましくは20体積%以上の放射状酸化亜鉛粒子を含有することが好ましい。 The compounding quantity of the said radial zinc oxide particle in the heat dissipation resin composition of this invention can be arbitrarily determined according to the performance of resin composition, such as the target heat dissipation performance and the hardness of a resin composition. In order to sufficiently develop the heat dissipation performance of the radial zinc oxide particles, the radial zinc oxide particles may be contained in an amount of 10% by volume or more, more preferably 20% by volume or more based on the total solid content in the resin composition. preferable.
本発明の放熱性樹脂組成物が熱成型用の樹脂組成物である場合、用途によって樹脂成分を自由に選択することができる。例えば、熱源と放熱板に接着し密着させる場合には、シリコーン樹脂やアクリル樹脂のような接着性が高く硬度の低い樹脂を選択すれば良い。 When the heat-dissipating resin composition of the present invention is a resin composition for thermoforming, the resin component can be freely selected depending on the application. For example, when adhering and adhering to a heat source and a heat sink, a resin having high adhesiveness and low hardness such as silicone resin or acrylic resin may be selected.
本発明の放熱性樹脂組成物が塗料用の樹脂組成物である場合、樹脂は硬化性を有するものであっても、硬化性を有さないものであっても良い。塗料は、有機溶媒を含有する溶剤系のものであっても、水中に樹脂が溶解又は分散した水系のものであっても良い。このような放熱性塗料組成物も本発明の一つである。 When the heat radiating resin composition of the present invention is a resin composition for paint, the resin may be curable or non-curable. The paint may be a solvent-based one containing an organic solvent or a water-based one in which a resin is dissolved or dispersed in water. Such a heat dissipating coating composition is also one aspect of the present invention.
上記放射状酸化亜鉛粒子を放熱性フィラーとして使用する場合、鉱油又は合成油を含有する基油と混合した放熱性グリースとして使用することもできる。このような放熱性グリースとして使用する場合は、合成油としてα−オレフィン、ジエステル、ポリオールエステル、トリメリット酸エステル、ポリフェニルエーテル、アルキルフェニルエーテル等が使用できる。また、シリコーンオイルと混合した放熱性グリースとして使用することもできる。 When using the said radial zinc oxide particle as a heat dissipation filler, it can also be used as a heat dissipation grease mixed with the base oil containing mineral oil or synthetic oil. When used as such heat dissipating grease, α-olefin, diester, polyol ester, trimellitic acid ester, polyphenyl ether, alkylphenyl ether and the like can be used as synthetic oil. It can also be used as a heat dissipating grease mixed with silicone oil.
上記放射状酸化亜鉛粒子は、化粧料の原料として使用してもよい。上記放射状酸化亜鉛粒子は、滑りが良く感触が滑らかであるため、使用感に優れた化粧料を得ることができる。上記化粧料としては、ファンデーション、化粧下地、アイシャドウ、頬紅、マスカラ、口紅、サンスクリーン剤等を挙げることができる。本発明の化粧料は、油性化粧料、水性化粧料、O/W型化粧料、W/O型化粧料の任意の形態とすることができる。なかでも、ファンデーションにおいて特に好適に使用することができる。 The radial zinc oxide particles may be used as a raw material for cosmetics. Since the radial zinc oxide particles are slippery and have a smooth feel, a cosmetic having an excellent usability can be obtained. Examples of the cosmetics include foundations, makeup bases, eye shadows, blushers, mascara, lipsticks, sunscreen agents, and the like. The cosmetics of the present invention can be in any form of oily cosmetics, aqueous cosmetics, O / W type cosmetics, and W / O type cosmetics. Especially, it can use especially suitably in a foundation.
本発明の化粧料は、上記混合物を構成する成分以外に、化粧品分野において使用することができる任意の水性成分、油性成分を併用するものであってもよい。上記水性成分及び油性成分としては特に限定されず、例えば、油分、界面活性剤、保湿剤、高級アルコール、金属イオン封鎖剤、天然及び合成高分子、水溶性及び油溶性高分子、紫外線遮蔽剤、各種抽出液、無機及び有機顔料、無機及び有機粘土鉱物、金属石鹸処理又はシリコーンで処理された無機及び有機顔料、有機染料等の色剤、防腐剤、酸化防止剤、色素、増粘剤、pH調整剤、香料、冷感剤、制汗剤、殺菌剤、皮膚賦活剤等の成分を含有するものであってもよい。具体的には、以下に列挙した配合成分の1種又は2種以上を任意に配合して常法により目的の化粧料を製造することが可能である。これらの配合成分の配合量は、本発明の効果を損なわない範囲であれば特に限定されない。 The cosmetic of the present invention may be used in combination with any aqueous component or oily component that can be used in the cosmetic field, in addition to the components constituting the mixture. The aqueous component and the oil component are not particularly limited, and examples thereof include oils, surfactants, moisturizers, higher alcohols, sequestering agents, natural and synthetic polymers, water-soluble and oil-soluble polymers, UV shielding agents, Various extracts, inorganic and organic pigments, inorganic and organic clay minerals, inorganic and organic pigments treated with metal soaps or silicones, organic dyes and other colorants, preservatives, antioxidants, pigments, thickeners, pH You may contain components, such as a regulator, a fragrance | flavor, a cooling agent, an antiperspirant, a disinfectant, and a skin activator. Specifically, it is possible to produce any desired cosmetic by a conventional method by arbitrarily blending one or more of the blending ingredients listed below. The compounding amounts of these compounding components are not particularly limited as long as the effects of the present invention are not impaired.
上記油分としては特に限定されず、例えば、アボガド油、ツバキ油、タートル油、マカデミアナッツ油、トウモロコシ油、ミンク油、オリーブ油、ナタネ油、卵黄油、ゴマ油、パーシック油、小麦胚芽油、サザンカ油、ヒマシ油、アマニ油、サフラワー油、綿実油、エノ油、大豆油、落花生油、茶実油、カヤ油、コメヌカ油、シナギリ油、日本キリ油、ホホバ油、胚芽油、トリグリセリン、トリオクタン酸グリセリン、トリイソパルミチン酸グリセリン、カカオ脂、ヤシ油、馬脂、硬化ヤシ油、パーム油、牛脂、羊脂、硬化牛脂、パーム核油、豚脂、牛骨脂、モクロウ核油、硬化油、牛脚脂、モクロウ、硬化ヒマシ油、ミツロウ、カンデリラロウ、綿ロウ、カルナウバロウ、ベイベリーロウ、イボタロウ、鯨ロウ、モンタンロウ、ヌカロウ、ラノリン、カポックロウ、酢酸ラノリン、液状ラノリン、サトウキビロウ、ラノリン脂肪酸イソプロピル、ラウリン酸ヘキシル、還元ラノリン、ジョジョバロウ、硬質ラノリン、セラックロウ、POEラノリンアルコールエーテル、POEラノリンアルコールアセテート、POEコレステロールエーテル、ラノリン脂肪酸ポリエチレングリコール、POE水素添加ラノリンアルコールエーテル、流動パラフィン、オゾケライト、プリスタン、パラフィン、セレシン、スクワレン、ワセリン、マイクロクリスタリンワックス等を挙げることができる。 The oil content is not particularly limited. For example, avocado oil, camellia oil, turtle oil, macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, wheat germ oil, sasanqua oil, castor Oil, flaxseed oil, safflower oil, cottonseed oil, eno oil, soybean oil, peanut oil, tea seed oil, kaya oil, rice bran oil, cinnagari oil, Japanese kiri oil, jojoba oil, germ oil, triglycerin, glycerin trioctanoate, Glycerin triisopalmitate, cocoa butter, coconut oil, horse fat, hydrogenated coconut oil, palm oil, beef tallow, sheep fat, hydrogenated beef tallow, palm kernel oil, pork tallow, beef bone oil, owl kernel oil, hydrogenated oil, cow leg Fat, Owl, Hardened castor oil, Beeswax, Candelilla wax, Cotton wax, Carnauba wax, Bayberry wax, Ibotaro, Whale wax, Montan wax, Nukarou, Norin, Kapok wax, Lanolin acetate, Liquid lanolin, Sugar cane wax, Lanolin fatty acid isopropyl, Hexyl laurate, Reduced lanolin, Jojoba wax, Hard lanolin, Shellac wax, POE lanolin alcohol ether, POE lanolin alcohol acetate, POE cholesterol ether, lanolin fatty acid polyethylene glycol POE hydrogenated lanolin alcohol ether, liquid paraffin, ozokerite, pristane, paraffin, ceresin, squalene, petrolatum, microcrystalline wax and the like.
上記親油性非イオン界面活性剤としては特に限定されず、例えば、ソルビタンモノオレエート、ソルビタンモノイソステアレート、ソルビタンモノラウレート、ソルビタンモノパルミテート、ソルビタンモノステアレート、ソルビタンセスキオレエート、ソルビタントリオレエート、ペンタ−2−エチルヘキシル酸ジグリセロールソルビタン、テトラ−2−エチルヘキシル酸ジグリセロールソルビタン等のソルビタン脂肪酸エステル類、モノ綿実油脂肪酸グリセリン、モノエルカ酸グリセリン、セスキオレイン酸グリセリン、モノステアリン酸グリセリン、α,α’−オレイン酸ピログルタミン酸グリセリン、モノステアリン酸グリセリンリンゴ酸等のグリセリンポリグリセリン脂肪酸類、モノステアリン酸プロピレングリコール等のプロピレングリコール脂肪酸エステル類、硬化ヒマシ油誘導体、グリセリンアルキルエーテル等を挙げることができる。 The lipophilic nonionic surfactant is not particularly limited. For example, sorbitan monooleate, sorbitan monoisostearate, sorbitan monolaurate, sorbitan monopalmitate, sorbitan monostearate, sorbitan sesquioleate, sorbitan trioleate. Sorbitan fatty acid esters such as diglycerol sorbitan penta-2-ethylhexylate, diglycerol sorbitan tetra-2-ethylhexylate, mono-cotton oil fatty acid glycerin, glyceryl monoerucate, glyceryl sesquioleate, glyceryl monostearate, α, α '-Glycerol polyglycerin fatty acids such as glyceryl oleate pyroglutamate, glyceryl monostearate malate, propylene glycol monostearate Glycol fatty acid esters, hardened castor oil derivatives, glycerin alkyl ethers and the like.
親水性非イオン界面活性剤としては特に限定されず、例えば、POEソルビタンモノオレエート、POEソルビタンモノステアレート、POEソルビタンテトラオレエート等のPOEソルビタン脂肪酸エステル類、POEソルビットモノラウレート、POEソルビットモノオレエート、POEソルビットペンタオレエート、POEソルビットモノステアレート等のPOEソルビット脂肪酸エステル類、POEグリセリンモノステアレート、POEグリセリンモノイソステアレート、POEグリセリントリイソステアレート等のPOEグリセリン脂肪酸エステル類、POEモノオレエート、POEジステアレート、POEモノジオレエート、システアリン酸エチレングリコール等のPOE脂肪酸エステル類、POEラウリルエーテル、POEオレイルエーテル、POEステアリルエーテル、POEベヘニルエーテル、POE2−オクチルドデシルエーテル、POEコレスタノールエーテル等のPOEアルキルエーテル類、POEオクチルフェニルエーテル、POEノニルフェニルエーテル、POEジノニルフェニルエーテル等のPOEアルキルフェニルエーテル類、ブルロニック等のプルアロニック型類、POE・POPセチルエーテル、POE・POP2−デシルテトラデシルエーテル、POE・POPモノブチルエーテル、POE・POP水添ラノリン、POE・POPグリセリンエーテル等のPOE・POPアルキルエーテル類、テトロニック等のテトラPOE・テトラPOPエチレンジアミン縮合物類、POEヒマシ油、POE硬化ヒマシ油、POE硬化ヒマシ油モノイソステアレート、POE硬化ヒマシ油トリイソステアレート、POE硬化ヒマシ油モノピログルタミン酸モノイソステアリン酸ジエステル、POE硬化ヒマシ油マレイン酸等のPOEヒマシ油硬化ヒマシ油誘導体、POEソルビットミツロウ等のPOEミツロウ・ラノリン誘導体、ヤシ油脂肪酸ジエタノールアミド、ラウリン酸モノエタノールアミド、脂肪酸イソプロパノールアミド等のアルカノールアミド、POEプロピレングリコール脂肪酸エステル、POEアルキルアミン、POE脂肪酸アミド、ショ糖脂肪酸エステル、POEノニルフェニルホルムアルデヒド縮合物、アルキルエトキシジメチルアミンオキシド、トリオレイルリン酸等を挙げることができる。 The hydrophilic nonionic surfactant is not particularly limited. For example, POE sorbitan fatty acid esters such as POE sorbitan monooleate, POE sorbitan monostearate, POE sorbitan tetraoleate, POE sorbite monolaurate, and POE sorbite mono POE sorbite fatty acid esters such as oleate, POE sorbite pentaoleate, POE sorbite monostearate, POE glycerin fatty acid esters such as POE glycerol monostearate, POE glycerol monoisostearate, POE glycerol triisostearate, POE POE fatty acid esters such as monooleate, POE distearate, POE monodiolate, ethylene glycol stearate, POE lauryl ether, POE POE alkyl ethers such as yl ether, POE stearyl ether, POE behenyl ether, POE 2 -octyldodecyl ether, POE cholestanol ether, POE alkyl phenyl ethers such as POE octyl phenyl ether, POE nonyl phenyl ether, POE dinonyl phenyl ether Pluronic type such as brulonic, POE / POP cetyl ether, POE / POP2-decyltetradecyl ether, POE / POP monobutyl ether, POE / POP hydrogenated lanolin, POE / POP alkyl ethers such as POE / POP glycerin ether, Tetronic PEO / TetraPOP ethylenediamine condensates, POE castor oil, POE hydrogenated castor oil, POE hydrogenated castor oil monoisos POE castor oil triisostearate, POE cured castor oil monopyroglutamic acid monoisostearic acid diester, POE castor oil cured castor oil derivatives such as POE cured castor oil maleic acid, POE beeswax and lanolin derivatives such as POE sorbite beeswax, Alkanolamides such as coconut oil fatty acid diethanolamide, lauric acid monoethanolamide, fatty acid isopropanolamide, POE propylene glycol fatty acid ester, POE alkylamine, POE fatty acid amide, sucrose fatty acid ester, POE nonylphenyl formaldehyde condensate, alkylethoxydimethylamine Examples thereof include oxide and trioleyl phosphate.
その他の界面活性剤としては、例えば、脂肪酸セッケン、高級アルキル硫酸エステル塩、POEラウリル硫酸トリエタノールアミン、アルキルエーテル硫酸エステル塩等のアニオン界面活性剤、アルキルトリメチルアンモニウム塩、アルキルピリジニウム塩、アルキル四級アンモニウム塩、アルキルジメチルベンジルアンモニウム塩、POEアルキルアミン、アルキルアミン塩、ポリアミン脂肪酸誘導体等のカチオン界面活性剤、及び、イミダゾリン系両性界面活性剤、ベタイン系界面活性剤等の両性界面活性剤を安定性及び皮膚刺激性に問題のない範囲で配合してもよい。 Examples of other surfactants include anionic surfactants such as fatty acid soaps, higher alkyl sulfates, POE lauryl sulfate triethanolamine, alkyl ether sulfates, alkyltrimethylammonium salts, alkylpyridinium salts, alkyl quaternary salts. Stabilizes cationic surfactants such as ammonium salts, alkyldimethylbenzylammonium salts, POE alkylamines, alkylamine salts, polyamine fatty acid derivatives, and amphoteric surfactants such as imidazoline-based amphoteric surfactants and betaine-based surfactants. And you may mix | blend in the range which does not have a problem in skin irritation.
上記保湿剤としては特に限定されず、例えば、キシリトール、ソルビトール、マルチトール、コンドロイチン硫酸、ヒアルロン酸、ムコイチン硫酸、カロニン酸、アテロコラーゲン、コレステリル−12−ヒドロキシステアレート、乳酸ナトリウム、胆汁酸塩、dl−ピロリドンカルボン酸塩、短鎖可溶性コラーゲン、ジグリセリン(EO)PO付加物、イサイヨバラ抽出物、セイヨウノコギリソウ抽出物、メリロート抽出物等を挙げることができる。 The moisturizing agent is not particularly limited, and examples thereof include xylitol, sorbitol, maltitol, chondroitin sulfate, hyaluronic acid, mucoitin sulfate, caronic acid, atelocollagen, cholesteryl-12-hydroxystearate, sodium lactate, bile salt, dl- Examples include pyrrolidone carboxylate, short-chain soluble collagen, diglycerin (EO) PO adduct, Isaiyobara extract, yarrow extract, and merirot extract.
上記高級アルコールとしては特に限定されず、例えば、ラウリルアルコール、セチルアルコール、ステアリルアルコール、ベヘニルアルコール、ミリスチルアルコール、オレイルアルコール、セトステアリルアルコール等の直鎖アルコール、モノステアリルグリセリンエーテル(バチルアルコール)、2−デシルテトラデシノール、ラノリンアルコール、コレステロール、フィトステロール、ヘキシルドデカノール、イソステアリルアルコール、オクチルドデカノール等の分枝鎖アルコール等を挙げることができる。 The higher alcohol is not particularly limited, and examples thereof include linear alcohols such as lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, cetostearyl alcohol, monostearyl glycerin ether (batyl alcohol), 2-decyl. Examples thereof include branched chain alcohols such as tetradecinol, lanolin alcohol, cholesterol, phytosterol, hexyldodecanol, isostearyl alcohol, octyldodecanol, and the like.
金属イオン封鎖剤としては特に限定されず、例えば、1−ヒドロキシエタン−1,1− ジフォスホン酸、1−ヒドロキシエタン−1,1−ジフォスホン酸四ナトリウム塩、クエン酸ナトリウム、ポリリン酸ナトリウム、メタリン酸ナトリウム、グルコン酸、リン酸、クエン酸、アスコルビン酸、コハク酸、エデト酸等を挙げることができる。 The sequestering agent is not particularly limited. For example, 1-hydroxyethane-1,1-diphosphonic acid, 1-hydroxyethane-1,1-diphosphonic acid tetrasodium salt, sodium citrate, sodium polyphosphate, metaphosphoric acid Examples thereof include sodium, gluconic acid, phosphoric acid, citric acid, ascorbic acid, succinic acid, edetic acid and the like.
上記天然の水溶性高分子としては特に限定されず、例えば、アラアビアガム、トラガカントガム、ガラクタン、グアガム、キャロブガム、カラヤガム、カラギーナン、ペクチン、カンテン、クインスシード(マルメロ)、アルゲコロイド(カッソウエキス)、デンプン(コメ、トウモロコシ、バレイショ、コムギ)、グリチルリチン酸等の植物系高分子、キサンタンガム、デキストラン、サクシノグルカン、プルラン等の微生物系高分子、コラーゲン、カゼイン、アルブミン、ゼラチン等の動物系高分子を挙げることができる。 The natural water-soluble polymer is not particularly limited. For example, arabia gum, tragacanth gum, galactan, guar gum, carob gum, caraya gum, carrageenan, pectin, agar, quince seed (malmello), alge colloid (guckweed extract), starch (rice, rice, Corn, potato, wheat), plant polymers such as glycyrrhizic acid, microbial polymers such as xanthan gum, dextran, succinoglucan and pullulan, and animal polymers such as collagen, casein, albumin and gelatin. .
半合成の水溶性高分子としては特に限定されず、例えば、カルボキシメチルデンプン、メチルヒドロキシプロピルデンプン等のデンプン系高分子、メチルセルロース、ニトロセルロース、エチルセルロース、メチルヒドロキシプロピルセルロース、ヒドロキシエチルセルロース、セルロース硫酸ナトリウム、ヒドロキシプロピルセルロース、カルボキシメチルセルロースナトリウム(CMC)、結晶セルロース、セルロース末等のセルロース系高分子、アルギン酸ナトリウム、アルギン酸プロピレングリコールエステル等のアルギン酸系高分子等を挙げることができる。 The semi-synthetic water-soluble polymer is not particularly limited. For example, starch-based polymers such as carboxymethyl starch and methylhydroxypropyl starch, methylcellulose, nitrocellulose, ethylcellulose, methylhydroxypropylcellulose, hydroxyethylcellulose, sodium cellulose sulfate, Examples thereof include cellulose polymers such as hydroxypropylcellulose, sodium carboxymethylcellulose (CMC), crystalline cellulose, and cellulose powder, and alginic acid polymers such as sodium alginate and propylene glycol alginate.
合成の水溶性高分子としては特に限定されず、例えば、ポリビニルアルコール、ポリビニルメチルエーテル、ポリビニルピロリドン等のビニル系高分子、ポリエチレングリコール20,000、40,000、60,000等のポリオキシエチレン系高分子、ポリオキシエチレンポリオキシプロピレン共重合体共重合系高分子、ポリアクリル酸ナトリウム、ポリエチルアクリレート、ポリアクリルアミド等のアクリル系高分子、ポリエチレンイミン、カチオンポリマー等を挙げることができる。 The synthetic water-soluble polymer is not particularly limited, and examples thereof include vinyl polymers such as polyvinyl alcohol, polyvinyl methyl ether, and polyvinyl pyrrolidone, and polyoxyethylene polymers such as polyethylene glycol 20,000, 40,000, and 60,000. Examples thereof include polymers, polyoxyethylene polyoxypropylene copolymer copolymer polymers, acrylic polymers such as sodium polyacrylate, polyethyl acrylate and polyacrylamide, polyethyleneimine, and cationic polymers.
無機の水溶性高分子としては特に限定されず、例えば、ベントナイト、ケイ酸A1Mg(ビーガム)、ラポナイト、ヘクトライト、無水ケイ酸等を挙げることができる。 The inorganic water-soluble polymer is not particularly limited, and examples thereof include bentonite, silicate A1Mg (beegum), laponite, hectorite, and silicic anhydride.
紫外線遮蔽剤としては特に限定されず、例えば、パラアミノ安息香酸(以下PABAと略す)、PABAモノグリセリンエステル、N,N−ジプロポキシPABAエチルエステル、N,N−ジエトキシPABAエチルエステル、N,N−ジメチルPABAエチルエステル、N,N−ジメチルPABAブチルエステル等の安息香酸系紫外線遮蔽剤;ホモメンチル−N−アセチルアントラニレート等のアントラニル酸系紫外線遮蔽剤;アミルサリシレート、メンチルサリシレート、ホモメンチルサリシレート、オクチルサリシレート、フェニルサリシレート、ベンジルサリシレート、p−イソプロパノールフェニルサリシレート等のサリチル酸系紫外線遮蔽剤;オクチルシンナメート、エチル−4−イソプロピルシンナメート、メチル−2,5−ジイソプロピルシンナメート、エチル−2,4−ジイソプロピルシンナメート、メチル−2,4−ジイソプロピルシンナメート、プロピル−p−メトキシシンナメート、イソプロピル−p−メトキシシンナメート、イソアミル−p−メトキシシンナメート、2−エトキシエチル−p−メトキシシンナメート、シクロヘキシル−p−メトキシシンナメート、エチル−α−シアノ−β−フェニルシンナメート、2−エチルヘキシル−α−シアノ−β−フェニルシンナメート、グリセリルモノ−2−エチルヘキサノイル−ジパラメトキシシンナメート等のケイ皮酸系紫外線遮蔽剤;2,4−ジヒドロキシベンゾフェノン、2,2’−ジヒドロキシ−4−メトキシベンゾフェノン、2,2’−ジヒドロキシ−4,4’−ジメトキシベンゾフェノン、2,2’,4,4’−テトラヒドロキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン、2−ヒドロキシ−4−メトキシ−4’−メチルベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸塩、4−フェニルベンゾフェノン、2−エチルヘキシル−4’−フェニル−ベンゾフェノン−2−カルボキシレート、2−ヒドロキシ−4−n−オクトキシベンゾフェノン、4−ヒドロキシ−3−カルボキシベンゾフェノン等のベンゾフェノン系紫外線遮蔽剤;3−(4’−メチルベンジリデン)−d,l−カンファー、3−ベンジリデン−d,l−カンファー、ウロカニン酸、ウロカニン酸エチルエステル、2−フェニル−5−メチルベンゾキサゾール、2,2’−ヒドロキシ−5−メチルフェニルベンゾトリアゾール、2−(2’−ヒドロキシ−5’−t−オクチルフェニル)ベンゾトリアゾール、2−(2’−ヒドロキシ−5’−メチルフェニルベンゾトリアゾール、ジベンザラジン、ジアニソイルメタン、4−メトキシ−4’−t−ブチルジベンゾイルメタン、5−(3,3−ジメチル−2−ノルボルニリデン)−3−ペンタン−2−オン等を挙げることができる。 The ultraviolet screening agent is not particularly limited. For example, paraaminobenzoic acid (hereinafter abbreviated as PABA), PABA monoglycerin ester, N, N-dipropoxy PABA ethyl ester, N, N-diethoxy PABA ethyl ester, N, N-dimethyl Benzoic acid UV screening agents such as PABA ethyl ester and N, N-dimethyl PABA butyl ester; Anthranilic acid UV screening agents such as homomenthyl-N-acetylanthranylate; Amyl salicylate, menthyl salicylate, homomenthyl salicylate, octyl salicylate , Salicylic acid UV screening agents such as phenyl salicylate, benzyl salicylate, p-isopropanol phenyl salicylate; octylcinnamate, ethyl-4-isopropylcinnamate, methyl-2,5- Isopropyl cinnamate, ethyl-2,4-diisopropyl cinnamate, methyl-2,4-diisopropyl cinnamate, propyl-p-methoxycinnamate, isopropyl-p-methoxycinnamate, isoamyl-p-methoxycinnamate, 2- Ethoxyethyl-p-methoxycinnamate, cyclohexyl-p-methoxycinnamate, ethyl-α-cyano-β-phenylcinnamate, 2-ethylhexyl-α-cyano-β-phenylcinnamate, glyceryl mono-2-ethylhexa Cinnamic acid-based ultraviolet screening agents such as noyl-diparamethoxycinnamate; 2,4-dihydroxybenzophenone, 2,2′-dihydroxy-4-methoxybenzophenone, 2,2′-dihydroxy-4,4′-dimethoxybenzophenone , 2, 2 ', 4,4'-tetrahydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfonate, 4 -Benzophenone-based UV shielding agents such as phenylbenzophenone, 2-ethylhexyl-4'-phenyl-benzophenone-2-carboxylate, 2-hydroxy-4-n-octoxybenzophenone, 4-hydroxy-3-carboxybenzophenone; (4′-methylbenzylidene) -d, l-camphor, 3-benzylidene-d, l-camphor, urocanic acid, urocanic acid ethyl ester, 2-phenyl-5-methylbenzoxazole, 2,2′-hydroxy- 5-methylphenylbenzotri Sol, 2- (2′-hydroxy-5′-t-octylphenyl) benzotriazole, 2- (2′-hydroxy-5′-methylphenylbenzotriazole), dibenzalazine, dianisoylmethane, 4-methoxy-4′- Examples thereof include t-butyldibenzoylmethane and 5- (3,3-dimethyl-2-norbornylidene) -3-pentan-2-one.
その他薬剤成分としては特に限定されず、例えば、ビタミンA油、レチノール、パルミチン酸レチノール、イノシット、塩酸ピリドキシン、ニコチン酸ベンジル、ニコチン酸アミド、ニコチン酸DL−α−トコフェロール、アルコルビン酸リン酸マグネシウム、2−O−α−D−グルコピラノシル−L−アスコルビン酸、ビタミンD2(エルゴカシフェロール)、dl−α−トコフェロール、酢酸dl−α−トコフェロール、パントテン酸、ビオチン等のビタミン類;エストラジオール、エチニルエストラジオール等のホルモン;アルギニン、アスパラギン酸、シスチン、システイン、メチオニン、セリン、ロイシン、トリプトファン等のアミノ酸;アラントイン、アズレン等の抗炎症剤、アルブチン等の美白剤、;タンニン酸等の収斂剤;L−メントール、カンフル等の清涼剤やイオウ、塩化リゾチーム、塩化ピリドキシン等を挙げることができる。 Other drug components are not particularly limited and include, for example, vitamin A oil, retinol, retinol palmitate, inosit, pyridoxine hydrochloride, benzyl nicotinate, nicotinamide, nicotinic acid DL-α-tocopherol, magnesium ascorbate phosphate, 2 Vitamins such as -O-α-D-glucopyranosyl-L-ascorbic acid, vitamin D2 (ergocaciferol), dl-α-tocopherol, dl-α-tocopherol acetate, pantothenic acid, biotin; estradiol, ethinylestradiol, etc. Hormones; amino acids such as arginine, aspartic acid, cystine, cysteine, methionine, serine, leucine and tryptophan; anti-inflammatory agents such as allantoin and azulene; whitening agents such as arbutin; astringents such as tannic acid; L Menthol, cooling agents and sulfur camphor such as, lysozyme chloride, can be mentioned pyridoxine chloride, and the like.
各種の抽出液としては特に限定されず、例えば、ドクダミエキス、オウバクエキス、メリロートエキス、オドリコソウエキス、カンゾウエキス、シャクヤクエキス、サボンソウエキス、ヘチマエキス、キナエキス、ユキノシタエキス、クララエキス、コウホネエキス、ウイキョウエキス、サクラソウエキス、バラエキス、ジオウエキス、レモンエキス、シコンエキス、アロエエキス、ショウブ根エキス、ユーカリエキス、スギナエキス、セージエキス、タイムエキス、茶エキス、海藻エキス、キューカンバーエキス、チョウジエキス、キイチゴエキス、メリッサエキス、ニンジンエキス、マロニエエキス、モモエキス、桃葉エキス、クワエキス、ヤグルマギクエキス、ハマメリスエキス、プラセンタエキス、胸腺抽出物、シルク抽出液、甘草エキス等を挙げることができる There are no particular limitations on the various extracts, for example, Dokudami extract, Oat extract, Merirot extract, Odorikosou extract, Licorice extract, Peonies extract, Soap extract, Loofah extract, Kina extract, Yukinoshita extract, Clara extract, Kouhone extract, Fennel Extract, Primrose Extract, Rose Extract, Giant Extract, Lemon Extract, Shikon Extract, Aloe Extract, Shobu Root Extract, Eucalyptus Extract, Horsetail Extract, Sage Extract, Thyme Extract, Tea Extract, Seaweed Extract, Cucumber Extract, Clove Extract, Raspberry Extract, Melissa Extract , Carrot extract, marronnier extract, peach extract, peach leaf extract, mulberry extract, cornflower extract, hamamelis extract, placenta extract, thymus extract, silk extract, licorice Mention may be made of a kiss, etc.
上記各種粉体としては、ベンガラ、黄酸化鉄、黒酸化鉄、雲母チタン、酸化鉄被覆雲母チタン、酸化チタン被覆ガラスフレーク等の光輝性着色顔料、マイカ、タルク、カオリン、セリサイト、二酸化チタン、シリカ等の無機粉末やポリエチレン末、ナイロン末、架橋ポリスチレン、セルロースパウダー、シリコーン末等の有機粉末等を挙げることができる。好ましくは、官能特性向上、化粧持続性向上のため、粉末成分の一部又は全部をシリコーン類、フッ素化合物、金属石鹸、油剤、アシルグルタミン酸塩等の物質にて、公知の方法で疎水化処理して使用される。また、本発明に該当しない他の酸化亜鉛粒子を混合して使用するものであってもよい。 Examples of the various powders include bengara, yellow iron oxide, black iron oxide, titanium mica, iron oxide-coated mica titanium, titanium oxide-coated glass flakes and other bright colored pigments, mica, talc, kaolin, sericite, titanium dioxide, Examples thereof include inorganic powders such as silica and organic powders such as polyethylene powder, nylon powder, crosslinked polystyrene, cellulose powder, and silicone powder. Preferably, a part or all of the powder component is hydrophobized by a known method with a substance such as silicones, fluorine compounds, metal soaps, oils, acyl glutamates in order to improve sensory characteristics and cosmetic durability. Used. Moreover, you may mix and use the other zinc oxide particle which does not correspond to this invention.
本発明の放射状酸化亜鉛粒子は、上述した化粧料や放熱性フィラーの他に、ゴムの加硫促進剤、塗料・インキ用顔料、フェライトやバリスタ等の電子部品、医薬品等の分野においても使用することができる。 The radial zinc oxide particles of the present invention are used in the fields of rubber vulcanization accelerators, paint / ink pigments, electronic parts such as ferrite and varistors, pharmaceuticals, etc. in addition to the cosmetics and heat dissipating fillers described above. be able to.
以下に、実施例を挙げて本発明を説明するが、本発明はこれらの実施例によって何ら限定されるものではない。 EXAMPLES The present invention will be described below with reference to examples, but the present invention is not limited to these examples.
(実施例1)
酢酸亜鉛二水和物(和光純薬工業社製)110.86gを水に溶解して酢酸亜鉛二水和物としての濃度が1.0mol/lとなる酢酸亜鉛水溶液500mlを調製した。続いて、アンモニア水(和光純薬工業社製、アンモニア含有量:25.0〜27.9重量%)163.75gを水で希釈してアンモニアの濃度が1.0mol/lとなるアンモニア水溶液2500mlを調製した。続いて、上記アンモニア水溶液中に上記酢酸亜鉛水溶液を添加し、攪拌しながら25℃で2時間反応した。反応後、ろ過、水洗、乾燥することにより白色粉末を得た。得られた粒子のサイズ・形態を走査型電子顕微鏡(SEM、JSM−5600、日本電子社製)で観察した。得られた電子顕微鏡写真を図1に示した。また、得られた粒子の組成をX線回折装置UltimaIII(リガク社製)で分析した。得られた粒子のX線回折のスペクトルを図2に示した。分析の結果、得られた粉末は斜方晶系のε−水酸化亜鉛粒子であることがわかった。続いて、得られたε−水酸化亜鉛粒子をアンモニア水(和光純薬工業社製、アンモニア含有量:25.0〜27.9重量%)に溶解し、水酸化亜鉛としての濃度が0.32mol/lとなる亜鉛アンミン錯体水溶液を調製した。続いて、容積1リットルのフラスコに水500mlを入れて密封し、還流、攪拌しながら100℃に加熱した後、上記亜鉛アンミン錯体水溶液100mlを上記の100℃に加熱した水中に10秒間で添加することで瞬間的に熱分解し、還流、攪拌しながら5分間熟成した。熟成後、ろ過、水洗し、110℃で12時間乾燥することにより、平均粒子径が3.4μmの放射状酸化亜鉛粒子を得た。得られた粒子のサイズ・形態を走査型電子顕微鏡(SEM、JSM−5600、日本電子社製)で観察した。得られた電子顕微鏡写真を図3に示した。また、より高倍率で観察した電子顕微鏡写真を図4に示した。また、得られた粒子の組成をX線回折装置UltimaIII(リガク社製)で分析した。得られた粒子のX線回折のスペクトルを図5に示した。これらの分析の結果から、得られた粒子は粒子の中心に位置する六角柱部分とその周りに放射状に成長した部分とで構成された放射状酸化亜鉛粒子であることがわかった。また、得られた粒子の物性の評価結果を表1に示した。Example 1
Zinc acetate dihydrate (manufactured by Wako Pure Chemical Industries, Ltd.) 110.86 g was dissolved in water to prepare 500 ml of an aqueous zinc acetate solution having a concentration of 1.0 mol / l as zinc acetate dihydrate. Subsequently, ammonia water (made by Wako Pure Chemical Industries, Ltd., ammonia content: 25.0 to 27.9% by weight) 163.75 g is diluted with water to give an ammonia aqueous solution 2500 ml in which the ammonia concentration becomes 1.0 mol / l. Was prepared. Subsequently, the zinc acetate aqueous solution was added to the ammonia aqueous solution and reacted at 25 ° C. for 2 hours with stirring. After the reaction, white powder was obtained by filtration, washing with water and drying. The size and form of the obtained particles were observed with a scanning electron microscope (SEM, JSM-5600, manufactured by JEOL Ltd.). The obtained electron micrograph is shown in FIG. The composition of the obtained particles was analyzed with an X-ray diffractometer Ultima III (manufactured by Rigaku Corporation). The X-ray diffraction spectrum of the obtained particles is shown in FIG. As a result of analysis, it was found that the obtained powder was orthorhombic ε-zinc hydroxide particles. Subsequently, the obtained ε-zinc hydroxide particles were dissolved in aqueous ammonia (manufactured by Wako Pure Chemical Industries, Ltd., ammonia content: 25.0 to 27.9 wt%), and the concentration as zinc hydroxide was 0.00. An aqueous zinc ammine complex solution having a concentration of 32 mol / l was prepared. Subsequently, 500 ml of water is put into a 1 liter flask, sealed, heated to 100 ° C. while refluxing and stirring, and then 100 ml of the aqueous zinc ammine complex solution is added to the water heated to 100 ° C. over 10 seconds. It was thermally decomposed instantaneously, and aged for 5 minutes while refluxing and stirring. After aging, filtration, washing with water, and drying at 110 ° C. for 12 hours, radial zinc oxide particles having an average particle size of 3.4 μm were obtained. The size and form of the obtained particles were observed with a scanning electron microscope (SEM, JSM-5600, manufactured by JEOL Ltd.). The obtained electron micrograph is shown in FIG. Moreover, the electron micrograph observed at higher magnification is shown in FIG. The composition of the obtained particles was analyzed with an X-ray diffractometer Ultima III (manufactured by Rigaku Corporation). The X-ray diffraction spectrum of the obtained particles is shown in FIG. From the results of these analyses, it was found that the obtained particles were radial zinc oxide particles composed of a hexagonal column portion located at the center of the particle and a portion grown radially around the hexagonal column portion. The evaluation results of the physical properties of the obtained particles are shown in Table 1.
(実施例2)
酢酸亜鉛二水和物(和光純薬工業社製)110.86gを水に溶解して酢酸亜鉛二水和物としての濃度が1.0mol/lとなる酢酸亜鉛水溶液500mlを調製した。続いて、アンモニア水(和光純薬工業社製、アンモニア含有量:25.0〜27.9重量%)163.75gを水で希釈してアンモニアの濃度が1.0mol/lとなるアンモニア水溶液2500mlを調製した。続いて、上記アンモニア水溶液中に上記酢酸亜鉛水溶液を添加し、攪拌しながら25℃で2時間反応した。反応後、ろ過、水洗、乾燥することにより斜方晶系のε−水酸化亜鉛粒子を得た。続いて、得られたε−水酸化亜鉛粒子をアンモニア水(和光純薬工業社製、アンモニア含有量:25.0〜27.9重量%)に溶解し、水酸化亜鉛としての濃度が0.32mol/lとなる亜鉛アンミン錯体水溶液を調製した。続いて、容積1リットルのフラスコに水500mlを入れ、還流、攪拌しながら100℃に加熱した後、上記亜鉛アンミン錯体水溶液100mlを上記の100℃に加熱した水中に10秒間で添加することで瞬間的に熱分解し、還流、攪拌しながら0.1分間熟成した。熟成後、ろ過、水洗し、110℃で12時間乾燥することにより、平均粒子径が2.0μmの放射状酸化亜鉛粒子を得た。得られた粒子のサイズ・形態を走査型電子顕微鏡(SEM、JSM−5600、日本電子社製)で観察した。得られた電子顕微鏡写真を図6に示した。また、より高倍率で観察した電子顕微鏡写真を図7に示した。また、得られた粒子の物性の評価結果を表1に示した。(Example 2)
Zinc acetate dihydrate (manufactured by Wako Pure Chemical Industries, Ltd.) 110.86 g was dissolved in water to prepare 500 ml of an aqueous zinc acetate solution having a concentration of 1.0 mol / l as zinc acetate dihydrate. Subsequently, ammonia water (made by Wako Pure Chemical Industries, Ltd., ammonia content: 25.0 to 27.9% by weight) 163.75 g is diluted with water to give an ammonia aqueous solution 2500 ml in which the ammonia concentration becomes 1.0 mol / l. Was prepared. Subsequently, the zinc acetate aqueous solution was added to the ammonia aqueous solution and reacted at 25 ° C. for 2 hours with stirring. After the reaction, orthorhombic ε-zinc hydroxide particles were obtained by filtration, washing with water and drying. Subsequently, the obtained ε-zinc hydroxide particles were dissolved in aqueous ammonia (manufactured by Wako Pure Chemical Industries, Ltd., ammonia content: 25.0 to 27.9 wt%), and the concentration as zinc hydroxide was 0.00. An aqueous zinc ammine complex solution having a concentration of 32 mol / l was prepared. Subsequently, 500 ml of water is placed in a 1 liter flask, heated to 100 ° C. while refluxing and stirring, and then added 100 ml of the aqueous zinc ammine complex solution to the water heated to 100 ° C. for 10 seconds. The mixture was thermally decomposed and aged for 0.1 minutes with reflux and stirring. After aging, filtration, washing with water, and drying at 110 ° C. for 12 hours, radial zinc oxide particles having an average particle size of 2.0 μm were obtained. The size and form of the obtained particles were observed with a scanning electron microscope (SEM, JSM-5600, manufactured by JEOL Ltd.). The obtained electron micrograph is shown in FIG. Moreover, the electron micrograph observed at higher magnification is shown in FIG. The evaluation results of the physical properties of the obtained particles are shown in Table 1.
(実施例3)
酢酸亜鉛二水和物(和光純薬工業社製)110.86gを水に溶解して酢酸亜鉛二水和物としての濃度が1.0mol/lとなる酢酸亜鉛水溶液500mlを調製した。続いて、アンモニア水(和光純薬工業社製、アンモニア含有量:25.0〜27.9重量%)163.75gを水で希釈してアンモニアの濃度が1.0mol/lとなるアンモニア水溶液2500mlを調製した。続いて、上記アンモニア水溶液中に上記酢酸亜鉛水溶液を添加し、攪拌しながら25℃で2時間反応した。反応後、ろ過、水洗、乾燥することにより斜方晶系のε−水酸化亜鉛粒子を得た。続いて、得られたε−水酸化亜鉛粒子をアンモニア水(和光純薬工業社製、アンモニア含有量:25.0〜27.9重量%)に溶解し、水酸化亜鉛としての濃度が0.32mol/lとなる亜鉛アンミン錯体水溶液を調製した。続いて、容積1リットルのフラスコに水500mlを入れ、還流、攪拌しながら100℃に加熱した後、上記亜鉛アンミン錯体水溶液100mlを上記の100℃に加熱した水中に10秒間で添加することで瞬間的に熱分解し、還流、攪拌しながら10分間熟成した。熟成後、ろ過、水洗し、110℃で12時間乾燥することにより、平均粒子径が5.0μmの放射状酸化亜鉛粒子を得た。得られた粒子のサイズ・形態を走査型電子顕微鏡(SEM、JSM−5600、日本電子社製)で観察した。得られた電子顕微鏡写真を図8に示した。また、より高倍率で観察した電子顕微鏡写真を図9に示した。また、得られた粒子の物性の評価結果を表1に示した。Example 3
Zinc acetate dihydrate (manufactured by Wako Pure Chemical Industries, Ltd.) 110.86 g was dissolved in water to prepare 500 ml of an aqueous zinc acetate solution having a concentration of 1.0 mol / l as zinc acetate dihydrate. Subsequently, ammonia water (made by Wako Pure Chemical Industries, Ltd., ammonia content: 25.0 to 27.9% by weight) 163.75 g is diluted with water to give an ammonia aqueous solution 2500 ml in which the ammonia concentration becomes 1.0 mol / l. Was prepared. Subsequently, the zinc acetate aqueous solution was added to the ammonia aqueous solution and reacted at 25 ° C. for 2 hours with stirring. After the reaction, orthorhombic ε-zinc hydroxide particles were obtained by filtration, washing with water and drying. Subsequently, the obtained ε-zinc hydroxide particles were dissolved in aqueous ammonia (manufactured by Wako Pure Chemical Industries, Ltd., ammonia content: 25.0 to 27.9 wt%), and the concentration as zinc hydroxide was 0.00. An aqueous zinc ammine complex solution having a concentration of 32 mol / l was prepared. Subsequently, 500 ml of water is placed in a 1 liter flask, heated to 100 ° C. while refluxing and stirring, and then added 100 ml of the aqueous zinc ammine complex solution to the water heated to 100 ° C. for 10 seconds. The mixture was thermally decomposed and aged for 10 minutes while refluxing and stirring. After aging, filtration, washing with water, and drying at 110 ° C. for 12 hours, radial zinc oxide particles having an average particle size of 5.0 μm were obtained. The size and form of the obtained particles were observed with a scanning electron microscope (SEM, JSM-5600, manufactured by JEOL Ltd.). The obtained electron micrograph is shown in FIG. Moreover, the electron micrograph observed at higher magnification is shown in FIG. The evaluation results of the physical properties of the obtained particles are shown in Table 1.
(比較例1)
酢酸亜鉛二水和物(和光純薬工業社製)110.86gを水に溶解して酢酸亜鉛二水和物としての濃度が1.0mol/lとなる酢酸亜鉛水溶液500mlを調製した。続いて、アンモニア水(和光純薬工業社製、アンモニア含有量:25.0〜27.9重量%)163.75gを水で希釈してアンモニアの濃度が1.0mol/lとなるアンモニア水溶液2500mlを調製した。続いて、上記アンモニア水溶液中に上記酢酸亜鉛水溶液を添加し、攪拌しながら25℃で2時間反応した。反応後、ろ過、水洗、乾燥することにより斜方晶系のε−水酸化亜鉛粒子を得た。続いて、得られたε−水酸化亜鉛粒子をアンモニア水(和光純薬工業社製、アンモニア含有量:25.0〜27.9重量%)に溶解し、水酸化亜鉛としての濃度が0.32mol/lとなる亜鉛アンミン錯体水溶液を調製した。続いて、容積1リットルのフラスコに上記アンミン錯体水溶液250mlを入れ、還流、攪拌しながら60分で100℃に昇温した後、100℃で180分間熟成した。熟成後、ろ過、水洗し、110℃で12時間乾燥することにより、平均粒子径が8.3μmの酸化亜鉛粒子を得た。得られた粒子のサイズ・形態を走査型電子顕微鏡(SEM、JSM−5600、日本電子社製)で観察した。得られた電子顕微鏡写真を図10に示した。また、得られた粒子の組成をX線回折装置UltimaIII(リガク社製)で分析した。得られた粒子のX線回折のスペクトルを図11に示した。電子顕微鏡写真から、得られた粒子は粒子が放射状に成長しているものの、粒子の中心に六角柱構造が形成されておらず、また、形状・サイズが不均一であることがわかった。また、X線回折のスペクトルから、不純物が混ざった酸化亜鉛の状態であり、かつ酸化亜鉛の板状面;(002)面のピーク強度;I(002)が大きく検出されI(002)/I(100)の値が大きくなっていることから、板状面方向への配向が生じていることがわかった。また、得られた粒子の物性の評価結果を表1に示した。(Comparative Example 1)
Zinc acetate dihydrate (manufactured by Wako Pure Chemical Industries, Ltd.) 110.86 g was dissolved in water to prepare 500 ml of an aqueous zinc acetate solution having a concentration of 1.0 mol / l as zinc acetate dihydrate. Subsequently, ammonia water (made by Wako Pure Chemical Industries, Ltd., ammonia content: 25.0 to 27.9% by weight) 163.75 g is diluted with water to give an ammonia aqueous solution 2500 ml in which the ammonia concentration becomes 1.0 mol / l. Was prepared. Subsequently, the zinc acetate aqueous solution was added to the ammonia aqueous solution and reacted at 25 ° C. for 2 hours with stirring. After the reaction, orthorhombic ε-zinc hydroxide particles were obtained by filtration, washing with water and drying. Subsequently, the obtained ε-zinc hydroxide particles were dissolved in aqueous ammonia (manufactured by Wako Pure Chemical Industries, Ltd., ammonia content: 25.0 to 27.9 wt%), and the concentration as zinc hydroxide was 0.00. An aqueous zinc ammine complex solution having a concentration of 32 mol / l was prepared. Subsequently, 250 ml of the above-mentioned ammine complex aqueous solution was placed in a 1 liter flask, heated to 100 ° C. over 60 minutes while refluxing and stirring, and then aged at 100 ° C. for 180 minutes. After aging, it was filtered, washed with water, and dried at 110 ° C. for 12 hours to obtain zinc oxide particles having an average particle size of 8.3 μm. The size and form of the obtained particles were observed with a scanning electron microscope (SEM, JSM-5600, manufactured by JEOL Ltd.). The obtained electron micrograph is shown in FIG. The composition of the obtained particles was analyzed with an X-ray diffractometer Ultima III (manufactured by Rigaku Corporation). The X-ray diffraction spectrum of the obtained particles is shown in FIG. From the electron micrograph, it was found that although the obtained particles were grown radially, a hexagonal column structure was not formed at the center of the particles, and the shape and size were not uniform. Further, from the X-ray diffraction spectrum, it is in the state of zinc oxide mixed with impurities, and the zinc oxide plate-like surface; the peak intensity of the (002) plane; Since the value of (100) was large, it was found that orientation in the plate-like surface direction occurred. The evaluation results of the physical properties of the obtained particles are shown in Table 1.
(比較例2)
酢酸亜鉛二水和物(和光純薬工業社製)110.86gを水に溶解して酢酸亜鉛二水和物としての濃度が1.0mol/lとなる酢酸亜鉛水溶液500mlを調製した。続いて、アンモニア水(和光純薬工業社製、アンモニア含有量:25.0〜27.9重量%)163.75gを水で希釈してアンモニアの濃度が1.0mol/lとなるアンモニア水溶液2500mlを調製した。続いて、上記アンモニア水溶液中に上記酢酸亜鉛水溶液を添加し、攪拌しながら25℃で2時間反応した。反応後、ろ過、水洗、乾燥することにより斜方晶系のε−水酸化亜鉛粒子を得た。続いて、得られたε−水酸化亜鉛粒子をアンモニア水(和光純薬工業社製、アンモニア含有量:25.0〜27.9重量%)に溶解し、水酸化亜鉛としての濃度が0.32mol/lとなる亜鉛アンミン錯体水溶液を調製した。続いて、容積1リットルのフラスコに上記アンミン錯体水溶液250mlを入れ、還流、攪拌しながら36分で60℃に昇温した後、60℃で180分間熟成した。熟成後、ろ過、水洗し、110℃で12時間乾燥することにより、平均粒子径が27.6μmの粒子を得た。得られた粒子のサイズ・形態を走査型電子顕微鏡(SEM、JSM−5600、日本電子社製)で観察した。得られた電子顕微鏡写真を図12に示した。また、得られた粒子の組をX線回折装置UltimaIII(リガク社製)で分析した。得られた粒子のX線回折のスペクトルを図13に示した。電子顕微鏡写真から、得られた粒子は形状・サイズが不均一であることがわかった。また、X線回折のスペクトルから、前駆体であるε−水酸化亜鉛が残留している状態となっており、反応が充分に進行していないことがわかった。また、得られた粒子の物性の評価結果を表1に示した。(Comparative Example 2)
Zinc acetate dihydrate (manufactured by Wako Pure Chemical Industries, Ltd.) 110.86 g was dissolved in water to prepare 500 ml of an aqueous zinc acetate solution having a concentration of 1.0 mol / l as zinc acetate dihydrate. Subsequently, ammonia water (made by Wako Pure Chemical Industries, Ltd., ammonia content: 25.0 to 27.9% by weight) 163.75 g is diluted with water to give an ammonia aqueous solution 2500 ml in which the ammonia concentration becomes 1.0 mol / l. Was prepared. Subsequently, the zinc acetate aqueous solution was added to the ammonia aqueous solution and reacted at 25 ° C. for 2 hours with stirring. After the reaction, orthorhombic ε-zinc hydroxide particles were obtained by filtration, washing with water and drying. Subsequently, the obtained ε-zinc hydroxide particles were dissolved in aqueous ammonia (manufactured by Wako Pure Chemical Industries, Ltd., ammonia content: 25.0 to 27.9 wt%), and the concentration as zinc hydroxide was 0.00. An aqueous zinc ammine complex solution having a concentration of 32 mol / l was prepared. Subsequently, 250 ml of the above-mentioned ammine complex aqueous solution was placed in a 1 liter flask, heated to 60 ° C. over 36 minutes while refluxing and stirring, and then aged at 60 ° C. for 180 minutes. After aging, the mixture was filtered, washed with water, and dried at 110 ° C. for 12 hours to obtain particles having an average particle diameter of 27.6 μm. The size and form of the obtained particles were observed with a scanning electron microscope (SEM, JSM-5600, manufactured by JEOL Ltd.). The obtained electron micrograph is shown in FIG. Moreover, the set of obtained particles was analyzed with an X-ray diffractometer Ultima III (manufactured by Rigaku Corporation). The X-ray diffraction spectrum of the obtained particles is shown in FIG. From the electron micrograph, it was found that the obtained particles were nonuniform in shape and size. Further, from the X-ray diffraction spectrum, it was found that the precursor ε-zinc hydroxide remained, and the reaction did not proceed sufficiently. The evaluation results of the physical properties of the obtained particles are shown in Table 1.
(比較例3)
酢酸亜鉛二水和物(和光純薬工業社製)110.86gを水に溶解して酢酸亜鉛二水和物としての濃度が1.0mol/lとなる酢酸亜鉛水溶液500mlを調製した。続いて、アンモニア水(和光純薬工業社製、アンモニア含有量:25.0〜27.9重量%)163.75gを水で希釈してアンモニアの濃度が1.0mol/lとなるアンモニア水溶液2500mlを調製した。続いて、上記アンモニア水溶液中に上記酢酸亜鉛水溶液を添加し、攪拌しながら25℃で2時間反応した。反応後、ろ過、水洗、乾燥することにより斜方晶系のε−水酸化亜鉛粒子を得た。続いて、得られたε−水酸化亜鉛粒子をアンモニア水(和光純薬工業社製、アンモニア含有量:25.0〜27.9重量%)に溶解し、水酸化亜鉛としての濃度が0.32mol/lとなる亜鉛アンミン錯体水溶液を調製した。続いて、容積1リットルのフラスコに水500mlを入れ、還流、攪拌しながら75℃に加熱した後、上記亜鉛アンミン錯体水溶液100mlを上記の75℃に加熱した水中に10秒間で添加し、還流、攪拌しながら5分間熟成した。しかし、液中において結晶が析出することはなく、生成物を得ることはできなかった。(Comparative Example 3)
Zinc acetate dihydrate (manufactured by Wako Pure Chemical Industries, Ltd.) 110.86 g was dissolved in water to prepare 500 ml of an aqueous zinc acetate solution having a concentration of 1.0 mol / l as zinc acetate dihydrate. Subsequently, ammonia water (made by Wako Pure Chemical Industries, Ltd., ammonia content: 25.0 to 27.9% by weight) 163.75 g is diluted with water to give an ammonia aqueous solution 2500 ml in which the ammonia concentration becomes 1.0 mol / l. Was prepared. Subsequently, the zinc acetate aqueous solution was added to the ammonia aqueous solution and reacted at 25 ° C. for 2 hours with stirring. After the reaction, orthorhombic ε-zinc hydroxide particles were obtained by filtration, washing with water and drying. Subsequently, the obtained ε-zinc hydroxide particles were dissolved in aqueous ammonia (manufactured by Wako Pure Chemical Industries, Ltd., ammonia content: 25.0 to 27.9 wt%), and the concentration as zinc hydroxide was 0.00. An aqueous zinc ammine complex solution having a concentration of 32 mol / l was prepared. Subsequently, 500 ml of water was placed in a 1 liter flask, heated to 75 ° C. while refluxing and stirring, and then 100 ml of the aqueous zinc ammine complex solution was added to the water heated to 75 ° C. over 10 seconds, and refluxed. The mixture was aged for 5 minutes with stirring. However, crystals did not precipitate in the liquid, and the product could not be obtained.
(X線回折のスペクトル、得られた粒子の組成)
図2、図5、図11、図13に示すX線回折のスペクトル、及び表1における得られた粒子の組成は、銅管球をもつX線回折装置UltimaIII(リガク社製)により分析した結果を示したものである。これらの結果から、実施例のものについては酸化亜鉛が得られていることが明らかである。図11から比較例1の酸化亜鉛粒子は不純物が混ざった状態であり、かつ酸化亜鉛の板状面;(002)面のピーク強度;I(002)が大きく検出されI(002)/I(100)の値が大きくなっていることから、板状面方向への配向が生じていることが明らかである。また、図13から、比較例2の酸化亜鉛粒子は、前駆体であるε−水酸化亜鉛が残留している状態となっており、熱分解が充分に進行していないことが明らかである。(X-ray diffraction spectrum, composition of the obtained particles)
The spectrum of the X-ray diffraction shown in FIGS. 2, 5, 11, and 13 and the composition of the particles obtained in Table 1 were analyzed by an X-ray diffractometer Ultima III (manufactured by Rigaku Corporation) having a copper tube. Is shown. From these results, it is clear that zinc oxide was obtained for the examples. From FIG. 11, the zinc oxide particles of Comparative Example 1 are in a state in which impurities are mixed, and the zinc oxide plate-like surface; (002) plane peak intensity; I (002) is detected to be large, and I (002) / I ( From the fact that the value of 100) is large, it is clear that the orientation in the plate-like surface direction occurs. Moreover, from FIG. 13, it is clear that the zinc oxide particles of Comparative Example 2 are in a state in which the precursor ε-zinc hydroxide remains, and the thermal decomposition does not proceed sufficiently.
(平均摩擦係数)
表1の平均摩擦係数は、上記実施例、比較例で得られる酸化亜鉛粒子をKES−SE摩擦感テスター(カトーテック社製)で測定した値である。センサーとしては、シリコーン接触子(人間の指を想定した凹凸が施されたシリコーンゴム製の摩擦子)を用いた。平均摩擦係数の値が小さい程、滑りが良く感触が滑らかであることを意味する。(Average friction coefficient)
The average friction coefficient of Table 1 is the value which measured the zinc oxide particle obtained by the said Example and comparative example with the KES-SE friction feeling tester (made by Kato Tech Co., Ltd.). As the sensor, a silicone contactor (silicone rubber friction element with unevenness assuming a human finger) was used. The smaller the average friction coefficient, the better the slip and the smoother the feel.
図4、7及び9より、本発明の放射状酸化亜鉛粒子は、粒子の中心に位置する六角柱部分とその周りに放射状に成長した部分とで構成された形状を有することがわかった。また、平均摩擦係数が小さいことから、感触が滑らかな酸化亜鉛粒子であることも示された。 4, 7 and 9, it was found that the radial zinc oxide particles of the present invention had a shape composed of a hexagonal column portion located at the center of the particle and a portion grown radially around the hexagonal column portion. Moreover, since the average friction coefficient was small, it was also shown that the zinc oxide particles had a smooth feel.
本発明の放射状酸化亜鉛粒子は、放熱性フィラー、放熱性樹脂組成物、放熱性グリース、放熱性塗料組成物及び化粧料の成分として使用することができる。 The radial zinc oxide particles of the present invention can be used as a component of a heat dissipating filler, a heat dissipating resin composition, a heat dissipating grease, a heat dissipating coating composition, and a cosmetic.
Claims (1)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011130579 | 2011-06-10 | ||
JP2011130579 | 2011-06-10 | ||
PCT/JP2012/064778 WO2012169612A1 (en) | 2011-06-10 | 2012-06-08 | Radial zinc-oxide particles, manufacturing method therefor, heat-dissipating filler, and cosmetic |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2012169612A1 JPWO2012169612A1 (en) | 2015-02-23 |
JP5954321B2 true JP5954321B2 (en) | 2016-07-20 |
Family
ID=47296166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013519540A Active JP5954321B2 (en) | 2011-06-10 | 2012-06-08 | Method for producing radial zinc oxide particles |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP5954321B2 (en) |
WO (1) | WO2012169612A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014148426A (en) * | 2013-01-31 | 2014-08-21 | Ishihara Sangyo Kaisha Ltd | Heat radiation property composition |
US9343202B2 (en) * | 2013-08-07 | 2016-05-17 | The Regents Of The University Of California | Transparent metal oxide nanoparticle compositions, methods of manufacture thereof and articles comprising the same |
JP7355501B2 (en) * | 2018-12-06 | 2023-10-03 | 曙ブレーキ工業株式会社 | Snow crystal-like zinc carbonate particles, snow crystal-like zinc oxide particles and their production method |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6232161A (en) * | 1985-08-06 | 1987-02-12 | Adogaa Kogyo Kk | Ink composition |
JP3890403B2 (en) * | 2001-12-04 | 2007-03-07 | 独立行政法人物質・材料研究機構 | Nitrogen-containing zinc oxide powder and method for producing the same |
JP2004149367A (en) * | 2002-10-31 | 2004-05-27 | Japan Science & Technology Agency | Aqueous solution for producing zinc oxide particle or film, and method for producing zinc oxide particle or film |
JP4304343B2 (en) * | 2005-09-08 | 2009-07-29 | 国立大学法人 千葉大学 | Zinc oxide fine particles, method for producing aggregates thereof and dispersion solution |
US8435485B2 (en) * | 2008-10-28 | 2013-05-07 | Sakai Chemical Industry Co., Ltd. | Method for producing zinc oxide using ammonium bromide, exoergic filler, resin composition, exoergic grease and exoergic coating composition comprising the zinc oxide |
JP5438530B2 (en) * | 2009-01-30 | 2014-03-12 | 富士フイルム株式会社 | Method for producing star-shaped zinc oxide particles |
-
2012
- 2012-06-08 WO PCT/JP2012/064778 patent/WO2012169612A1/en active Application Filing
- 2012-06-08 JP JP2013519540A patent/JP5954321B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JPWO2012169612A1 (en) | 2015-02-23 |
WO2012169612A1 (en) | 2012-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5929920B2 (en) | Surface-treated zinc oxide powder, antibacterial agent and antibacterial composition | |
JP5907166B2 (en) | Hexagonal plate-like zinc oxide particles, production method thereof, cosmetics containing the same, heat dissipating filler, heat dissipating resin composition, heat dissipating grease, and heat dissipating coating composition | |
JP5182456B2 (en) | Zinc oxide particles, production method thereof, cosmetics, heat dissipating filler, heat dissipating resin composition, heat dissipating grease and heat dissipating coating composition | |
JP5365763B1 (en) | Plate-like integrated spherical zinc oxide particles, production method thereof, cosmetics and heat-dissipating filler | |
JP5967087B2 (en) | Method for producing round zinc oxide particles | |
JP5910632B2 (en) | Composite powder and method for producing the same | |
JP5907167B2 (en) | Hexagonal columnar zinc oxide particles, method for producing the same, and cosmetics, heat dissipating filler, heat dissipating resin composition, heat dissipating grease and heat dissipating coating composition containing the same | |
JP5690661B2 (en) | Zinc oxide, method for producing zinc oxide, cosmetic, coating composition, and resin composition | |
JP5954321B2 (en) | Method for producing radial zinc oxide particles | |
JP5907248B2 (en) | Zinc carbonate salt particles, zinc oxide particles, production method thereof, heat dissipating filler and cosmetic | |
JP2014005255A (en) | Cosmetics | |
JP6065520B2 (en) | Method for producing zinc oxide particles | |
JP5910090B2 (en) | Composite powder, cosmetics and ink | |
EP4424641A1 (en) | Zinc oxide particles each having surface coated with organosilicon, method for producing same, cosmetic preparation, dispersion, heat dissipating filler and resin composition | |
JP2014088351A (en) | Rare earth doped barium sulfate and cosmetics | |
JP6051759B2 (en) | Method for producing titanium oxide particles for cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150206 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20151117 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160114 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160209 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160325 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160517 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160530 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5954321 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |